In vitro digestion models for dietary phenolic compounds by Aura, Anna-Marja
V
TT PU
BLICA
TIO
N
S 575
In vitro digestion m
odels for dietary phenolic com
pounds
A
nna-M
arja A
ura
Tätä julkaisua myy Denna publikation säljs av This publication is available from
VTT TIETOPALVELU VTT INFORMATIONSTJÄNST VTT INFORMATION SERVICE
PL 2000 PB 2000 P.O.Box 2000
02044 VTT 02044 VTT FI–02044 VTT, Finland
Puh. 020 722 4404 Tel. 020 722 4404 Phone internat. +358 20 722 4404
Faksi 020 722 4374 Fax 020 722 4374 Fax +358 20 722 4374
ISBN 951– 38– 6661– 0 (soft back ed.) ISBN 951– 38– 6662– 9 (URL: http://www.vtt.fi/inf/pdf/)
ISSN 1235– 0621 (soft back ed.) ISSN 1455– 0849 (URL: http://www.vtt.fi/inf/pdf/)
ESPOO 2005 VTT PUBLICATIONS 575
Anna-Marja Aura
In vitro digestion models for dietary
phenolic compounds
Plants offer a rich source of bioactive compounds, including a diverse group
of plant phenols. Epidemiological studies have shown the importance of
plant-based foods in the risk reduction of many chronic diseases. However,
our knowledge on the role of individual plant compounds, their metabolites
and mechanisms of action is far from complete. This thesis presents the
development of an in vitro model mimicking enzymatic digestion in the
upper intestine and application of an in vitro colon model to pure phenolic
compounds and to phenolics within  plant matrices. The in vitro enzymatic
digestion model was used to obtain a dietary fibre residue for an in vitro
colon fermentation model using a faecal inoculum. The microbial
metabolites of pure phenolic compounds were identified and quantified and
the role of microbiota in the overall metabolism of phenolics was discussed.
It was also shown that the presence of rye matrix influenced the formation
of mammalian lignans, possibly through the acidic components either
released from the matrix or converted by microbiota. These methods offer
a bridge between chemical food analyses and human physiology by
predicting the in vivo behaviour of complex foods and their components.
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Abstract 
The aim of this work was to develop in vitro digestion models for 
mimicking the physiological conditions of upper intestine and microbial 
conversions in the colon. The main emphasis was on the microbial 
metabolism of plant phenolic compounds: pure quercetin derivatives, pure 
anthocyanins and lignans from rye bran and flaxseed. 
When cereal samples are introduced to an in vitro colon model a removal 
of digestible components is needed. An enzymatic in vitro digestion 
model was developed for maximal starch removal from cereal samples. 
Pepsin, pancreatin and bile concentrations were optimized using an 
experimental design. Surprisingly, pepsin and bile also affected the extent 
of starch hydrolysis in synergy with pancreatin. 511 % of the original 
amount of starch remained in the residues of cereal products. Proteins 
were also partly hydrolysed. The in vitro enzymatic digestion model was 
used for the pretreatment of rye bran and flaxseed samples. 
An anaerobic in vitro colon model, conventionally used for the 
fermentation of non-digestible carbohydrates, was developed further for 
studying pure phenolic compounds. Human faecal microbiota from 
several healthy donors was used in the preparation of an inoculum. A low 
inoculum concentration was used for decreasing the metabolite 
concentration from the faecal background in the studies concerning pure 
flavonoids. A dense faecal suspension was suitable for the conversion of 
rye bran and flaxseed lignans to enterolactone when the plant matrix was 
present. 
Flavonoids were deconjugated and degraded to phenolic acids by faecal 
microbiota. Specific activities of the deconjugative enzymes from the 
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faecal inocula reflected the deconjugation rates of flavonoids. Quercetin 
aglycone was converted to hydroxyphenylacetic acids, but not to 
methylated phenolic acids. The extent of metabolism was 60 %, showing 
that ring-fission was a dominating route in the microbial metabolism of 
quercetin. Anthocyanins also underwent similar conversion, but the 
estimated extent of metabolite formation was low (less than 5 %). 
Protocatechuic acid was identified, and a phenoxyacid or a 
phenoxyaldehyde was proposed, as ring-fission products of cyanidin. In 
addition, it was suggested that anthocyanins undergo conjugation with an 
unknown moiety of 85 mass units. This conjugate was observed for 
several anthocyanins. 
Enterolactone production from plant lignans proceeded steadily and 
slowly for 48 hours in the in vitro colon model using the dense (16.7 %) 
faecal suspension. Flaxseed lignan conversion to enterolactone was 
suppressed by the presence of rye matrix. The enterolactone-producing 
microbiota may be sensitive to non-physiological, low pH values caused 
by acidic components from rye bran in the presence of microbiota. The 
presence of rye bran matrix did not interfere with enterolactone formation 
in an in vivo rat model. The difference in the response to the rye bran 
matrix may be due to the absorption of the released and metabolised 
compounds in rats. Rats may also adapt to the diet during their feeding 
period. This may have enhanced the enterolactone production, and may 
have further increased the difference between the bioactivity of the 
microbiota in the in vitro and in vivo models used in this study. 
Clinical human and animal trials describe end-point metabolism after 
adaptation to the test diet.  The in vitro colon model assists in elucidation 
of the role of microbiota in the metabolical network of human digestive 
system and it helps in identification of the crucial reactions. Applications 
of this method can be extended from the studies of food components to 
pharmaceutical research. 
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1. Introduction 
Epidemiological studies have shown that consumption of cereals, fruit, 
berries and vegetables is associated with lowered risk of some chronic 
diseases. Dietary recommendations are partly based on this 
epidemiological evidence. A balanced diet can be illustrated with a Food 
pyramid, indicating which foods should be eaten in abundance and 
which should be consumed only in small amounts. 
Most vitamins were identified between the years 1910 and 1950. 
Biologically active components that may diminish chronic disease risk 
have been recognized later, and their mechanism of action is still under 
investigation. Intake, availability and bioavailability (defined as 
absorption, transport into the circulatory system and delivery to the 
appropriate site of action) are important in estimating the potentially 
beneficial effects of dietary components on human health (Messina and 
Messina 1996; McGhie et al. 2003). 
The word bioaccessibility is defined as the amount of ingested 
compounds that are available for absorption in the gastrointestinal tract. 
Thus bioaccessibility refers to availability and luminal changes prior to 
absorption and is a part of bioavailability. The amount of bioaccessible 
compounds can be equal to or less than the amount that is released from 
the food matrix (Stahl et al. 2002). The release affects absorption of 
dietary components and the amount entering the colon either as free 
components or within the matrix. In addition, non-digestible components 
can be degraded by intestinal microbiota. Thus there are several 
phenomena which may change the structure of ingested compounds. 
When the metabolism of dietary compounds is studied in vivo, the overall 
metabolism of the ileum, liver, colon microbiota and intestinal tissues is 
included. In order to distinguish microbial conversions from those 
occurring in the tissues, it is necessary to isolate colonic microbes from 
the host. Consequently the present thesis is focused on the development 
and use of in vitro digestion models. The emphasis is on an in vitro colon 
model for studying microbial conversion of dietary phenolic compounds. 
When the phenolic compounds are introduced into the model within a 
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cereal matrix, digestible components need to be removed. An enzymatic 
digestion model is used for this purpose. 
1.1 Dietary fibre and phenolic compounds in plant 
foods 
1.1.1 Plant foods  
Plant foods consist of cereal grains, vegetables, legumes, fruits and berries. 
Their high intake is recommended because of their substantial content of 
dietary fibre (DF), vitamins, antioxidants and other non-nutrients (ECP 
consensus panel on cereals and cancer 1998). The outer layers of cereal 
grains rich in DF also contain putatively health-promoting compounds such 
as phytate, lignans (diphenolics), phenolic acids, alkylresorcinols and 
polyphenols (McIntosh et al. 2003). Dietary phenols are ubiquitous plant-
derived components. They can be divided into flavonoids, phenolic acids, 
stilbenes and lignans (Scalbert and Williamson 2000). 
DF was defined as the skeletal remains of plant cells that are resistant to 
digestion by enzymes of man (Trowell 1972) and this hypothesis was 
later extended also to include storage polysaccharides (Trowell et al. 
1976). Because oligosaccharides resist digestion in the upper intestine 
(van Loo et al. 1999), they were included in the most recent definition 
(AACC 2001). After the first definitions of DF, a hypothesis concerning 
the association of bioactive non-nutrients with the fibre complex was 
proposed in 1984 (Adlercreutz 1984). Thereafter, interest in the role of 
phenolic compounds in health and nutrition has been continuously 
expanding. 
The recommended daily intake of DF is 3 g/MJ, and according to the 
national FINDIET 2002 study the mean intake of DF in Finland is 2.9 
g/MJ and 2.4 g/MJ for women and men, respectively (Männistö et al. 
2003). The intake of plant phenols is dependent on the types of plant 
foods consumed. Thus the total daily intake of plant phenols is estimated 
to be between 150 and 1000 mg (Stahl et al. 2002). 
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1.1.2 Dietary fibre (DF) 
DF is most often quantified enzymatically by hydrolyzing starch and 
defining the soluble fraction by ethanol precipitation and the residual 
insoluble fraction gravimetrically (McCleary 2001; Asp et al. 1983; 
AOAC 2000a and b). The analyzed DF does not include small soluble 
oligosaccharides, which are not captured from the ethanol solution in the 
assay. Oligosaccharides are quantified separately by high-performance 
liquid chromatography (AOAC 2000c; McCleary et al. 2000; McCleary 
2001). Due to the evolution of the DF concept methods of analysis are 
also the subject of continuous debate and development. 
Chemically DF is heterogeneous, comprising of carbohydrates (cellulose, 
hemicellulose, arabinoxylans and β-glucans), polymeric uronic acids 
(pectic polysaccharides) and lignin (Englyst and Kingham 1990; 
McDougall et al. 1996; Truswell 1993). Cellulose, an insoluble DF 
component, has a high degree of ordering and pronounced crystallinity, 
which is caused by hydrogen bonding between parallel cellulose 
molecules (McDougall et al. 1996). Highly branched polymers, such as 
arabinoxylans and β-glucans, tend to be more soluble than less branched, 
linear polymers (Southgate 1995). Lignins are cell-wall polymers formed 
from phenyl propane units and they are highly insoluble (Begum et al. 
2004). Furthermore, resistant starch (RS) is one subclass of DF, and it can 
be physically inaccessible starch (for example in partly milled grains and 
seeds), raw starch granules (for example in raw potato and banana), or 
retrograded starch, which is formed in cooked and cooled potato, in bread 
and in corn flakes (Englyst et al. 1992). 
The major part of DF is carbohydrates, the primary structure of which 
consists of the intermolecular bonds between neutral monosaccharides. 
These glycosidic linkages are formed with two orientations (α or β) at 
any of the hydroxyl groups available. The orientation of bonds determines 
the secondary structure. In the α configuration the chain adopts a helical 
form and in the β configuration the chain has a flat ribbon-like appearance 
(McDougall et al. 1996; Southgate 1995). In their tertiary structure 
polysaccharides are cross-linked to each other with hydroxycinnamic acid 
ester dimers and structural proteins, which cause the development of 
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fibrous appearence (Iiyama et al. 1994; McDougall et al. 1996). These 
structures form the physical barrier enclosing a diverse pool of free and 
bound phenolic components. 
When DF is degraded, a wide range of substances are released along the 
gastrointestinal tract, but a part still remains within the matrix. Thus intact 
cells and cell fragments can effectively act as transport vehicles for these 
substances (Ratcliffe et al. 1997). DF has many functions in the 
gastrointestinal tract (McDougall et al. 1996). However, in the present 
work DF is only considered as a carrier of phenolic compounds and as a 
co-substrate for the colon microbiota. 
1.1.3 Phenolic compounds 
In nature, phenolic compounds occur mostly as glycosides. Flavonoids 
are the most abundant polyphenols in our diets (Scalbert and Williamson 
2000). Their flavonoid structure is based on the C6-C3-C6 skeleton. 
Flavonoids can be divided into several classes according to the degree of 
oxidation in the oxygen heterocycle and according to the degree of 
saturation in the C-ring (Clifford 2000a; Tomás-Barberán and Clifford 
2000a; Hollman and Arts 2000). 
The structures of phenolic acids are also diverse. Hydroxybenzoic acids are 
based on a C6-C1-skeleton (Tomás-Barberán and Clifford 2000b). Cinnamic 
acids are a series of trans-phenyl-3-propenoic acids with C6C3 structures 
differing in their ring substitution. They are commonly found as conjugates. 
Caffeic acid and its esters and ferulic acid are the most frequently 
encountered phenolic acids in plant foods. For example chlorogenic acid is 
an ester of caffeoyl and quinic acids, whereas ferulic acid is esterified with 
hemicelluloses (Clifford 2000b; Andreasen et al. 2000). 
Tannins have been defined as water-soluble, complex flavonoid polymers 
having a molecular weight between 500 and 3000 D (Chung et al. 1998). 
Condensed tannins can be formed for example from flavanols 
(proanthocyanidins) or phenolic acids esterified with a sugar (ellagitannins, 
gallotannins), possessing 1216 phenolic groups and 57 aromatic rings 
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per 1000 units of relative molecular weight (Santos-Buelga and Scalbert 
2000; Scalbert and Williamson 2000). Structures for different flavonoids, 
phenolic acids and condensed tannins are presented in Figure 1 and their 
typical sources are summarized in Table 1. 
Table 1. Phenolic compounds and examples of their typical sources. 
Phenolic compounds Typical sources 
Flavones 
Apigenin, luteolin 
 
Red pepper, cellery 
Flavonols 
Quercetin, myricetin 
 
Onion, kale, broccoli, beans, apple and tea 
Isoflavones 
Genistein, daidzein 
 
Soy 
Anthocyanidins 
Pelargonidin 
Cyanidin 
Delphinidin 
Peonidin 
Malvidin 
 
Red fruits (plum, grape) and berries 
(strawberry, raspberry, bilberry, 
blackberry, red and black currant) 
Flavanols 
Catechin 
Epicatechin 
Galloylated derivatives of above 
 
Tea, red wine, chocolate 
Flavanones 
Naringin, hesperetin 
 
Citrus fruits 
Phenolic acids 
Chlorogenic acid 
Ferulic acid 
 
Fruits, vegetables, coffee 
Cereals 
Tannins 
Ellagitannins 
 
Proanthocyanidins 
 
Cloudberry, raspberry, strawberry, nuts,  
pomegranate, plum, apricot, peach, grape 
Apple, pear, grape, tea, red wine, 
chocolate 
Stilbenes 
Resveratrols, viniferins 
 
Grapes and peanuts  
Plant lignans 
Syringaresinol, pinoresinol, 
isolariciresinol, lariciresinol, 
secoisolariciresinol, matairesinol 
 
Flaxseed, rye, berries, fruits 
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Chlorogenic acid is present in most fruits, vegetables and coffee and 
ferulic acid is abundant in cereals (Clifford 2000b; Andreasen et al. 
2000). Ellagitannins are present in some nuts, pomegranate, plum, apricot, 
peach and grape and are abundant in cloudberry, raspberry and strawberry 
(Clifford and Scalbert 2000; Kähkönen et al. 2001). 
Stilbenes are 1,2-diarylethens substituted with several hydroxy groups 
and sometimes a methoxy group. They are abundant in grapes, wine, 
peanuts and related products (Cassidy et al. 2000). Plant lignans are 
diphenolic compounds with a 1,4-diarylbutane structure and are found in 
cereals, berries and fruits (Cassidy et al. 2000; Mazur and Adlercreutz 
1998; Mazur et al. 2000). The structures of lignans are shown in Figure 2. 
The lignan content is highest in the outer layers of the kernel, where the 
DF content is also highest (Nilsson et al. 1997). Secoisolariciresinol and 
matairesinol were long considered to be the most important plant lignans 
in rye, but recently new lignans have been found. Thus, syringaresinol, 
pinoresinol, lariciresinol and isolariciresinol have also been quantified in 
rye. In rye bran the syringaresinol content is almost ten-fold the 
secoisolariciresinol and matairesinol contents (Heinonen et al. 2001). The 
quantified plant lignans of flaxseed include only secosisolariciresinol and 
matairesinol (Thompson et al. 1991), but pinoresinol, isolariciresinol and 
demethoxy-secoisolariciresinol have also been identified in flaxseed 
(Meagher et al. 1999; Sicilia et al. 2003). Flaxseed is still the richest source 
of plant lignans due to its high content of secoisolariciresinoldiglucoside. 
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Figure 1. Structures of some flavonoids, phenolic acids and condensed 
tannins. 
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Figure 2. Structures of plant lignans in rye. 
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1.1.4 Significance of plant foods, DF and phenolic 
compounds to human health 
According to a recent report published by The World Health Organization 
(WHO) there is varying strength of evidence for a correlation between 
consumption of DF, fruit, vegetables, whole grains and berries and 
reduced risk of various chronic diseases (WHO 2003). According to the 
report, reduced risk of cardiovascular diseases is associated with high 
consumption of fruit, vegetables and berries. The evidence for this 
correlation was considered as convincing, whereas the evidence for a 
correlation with DF consumption was merely rated as probable (WHO 
2003). Several epidemiological studies support the association of DF, 
vegetable and fruit intakes with lowered risk of coronary heart disease 
(Pereira et al. 2004; Mozaffarian et al. 2003; Liu et al. 2002a; Kris-
Etherton et al. 2002; Hu 2003; Rimm et al. 1996; Steinmetz and Potter 
1996; Pietinen et al. 1996). 
The association of DF intake and colon cancer has been under 
investigation in several epidemiological studies. The results of these 
studies have been contradictory, because some have failed to show an 
association of DF intake with reduced risk of colon cancer (Fuchs et al. 
1999; Pietinen et al. 1999; Terry et al. 2001), whereas others have 
provided supportive evidence (Bingham et al. 2003; Peters et al 2003; 
Slattery et al. 2004). In one study DF intake was inversely related to large 
bowel cancer incidence. Individuals with the lowest incidence of cancer 
consumed 35 g of total fibre per day and 12 g cereal fibre (Bingham et al. 
2003). A high intake of DF was also associated with a reduced risk of 
prevalent adenomas, particularly aggressive ones and those occurring in 
the colon (Peters et al. 2003). An inverse association of rectal cancer with 
an intake of plant food and fibre was seen at a threshold of approximately 
5 servings per day (Slattery et al. 2004). Bound phytochemicals, for 
example antioxidants in grains, can survive the stomach and the intestinal 
digestion and reach the colon. This may partly explain the correlation 
between grain consumption and the prevention of colon cancer as 
supported by epidemiological studies (Johnson 2002; Adom and Liu 
2002).  
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The term phytoestrogen has been used for lignans and isoflavones due to 
their structural similarity to estradiol-17β (Cassidy et al. 2000). Some 
phytoestrogens have particular affinity to the β-estrogen receptor (ERβ), 
causing an estrogenic or antiestrogenic effect and their intake has been 
associated with a decreased risk of hormone-related cancers (Tham et al. 
1998; Adlercreutz 2002). In the highest tertile of total fibre intake breast 
cancer risk was decreased by 29 % among premenopausal women. The 
effect was probably mediated by phytoestrogens (Bonilla-Fernandéz et al. 
2003). Plant lignans are converted to mammalian lignans, enterodiol and 
enterolactone, in the gastrointestinal (GI) tract (Setchell et al. 1981; 
Borriello et al. 1985; Thompson et al. 1991; Heinonen et al. 2001). One 
recent study has shown that intake of whole grains and vegetables 
determines the plasma enterolactone concentration (Johnsen et al. 2004). 
An association between high enterolactone concentration in urine and 
serum and reduced risk of breast cancer has been proposed (Ingram et al. 
1997; Pietinen et al. 2001; Hultén et al. 2002).  
A high intake of fruit and vegetables was associated with reduced risk of 
developing cancers. The evidence for this correlation was rated as 
probable in the report by the WHO (WHO 2003). It has been shown that 
the antioxidative properties of flavonoids and phenolic compounds are 
related to their structure (Rice-Evans et al. 1996). Antioxidants scavenge 
reactive oxygen species, which mediate signals in pathways initiating 
programmed cell death, apoptosis (Gee and Johnson 2001; Lopaczynski 
and Zeisel 2001). It has been shown that antioxidation did not correlate 
with in vitro antiproliferation activity (Meyers et al. 2003). At high doses 
flavonoids may act as mutagens, pro-oxidants that generate free radicals, 
and they can act as inhibitors of key enzymes involved in hormone 
metabolism (Skibola and Smith 2000). When the biological activities of 
phenolic compounds are studied in vitro, it is important to take into 
account the fact that the dietary phenols are present in the human body as 
conjugates, and at concentrations of 0.110 µmol/l (Kroon et al. 2004). 
Despite the epidemiological evidence that various phenolic compounds 
lower the risk of some chronic diseases, the mechanism of their action is 
still under debate. 
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1.1.5 Biological activities of colonic metabolites 
The importance of DF intake is associated with the rate and extent of 
fermentation. If the extent of fermentation is low, DF increases faecal 
bulk, reduces the transit time and binds and removes harmful components 
(mutagens, steroids, bile acids and xenobiotics) (McDougall et al. 1996). 
If the fermentation rate and extent are high, the health effects are 
mediated by the SCFA formation, for example by that of butyrate. 
Butyrate production in vivo was enhanced by the consumption of rye 
(Gråsten et al. 2000 and 2002; McIntosh et al. 2003), of resistant starch 
(Martin et al. 1998; Brouns et al. 2002) and of wheat pentosans (Gråsten 
et al. 2003). The butyrate concentration in the gut contents of a healthy 
individual can reach 1220 mM (Smith and German 1995). It has been 
shown that the increased production of butyrate in the colon further 
increases the circulating level of butyrate in the portal vein (Bach 
Knudsen et al. 2003b).  
As the colonic metabolites pass through the epithelium during absorption, 
local effects in the colon can be expected. The effect of butyrate may 
depend on the state of the colon epithelium. Butyrate has been shown to 
induce cell proliferation of the crypt base, and to induce apoptosis, 
programmed cell death, enhancing the healthy tissue turnover in normal 
colonocytes. In neoplastic cells butyrate inhibits proliferation at the crypt 
surface, the site of potential tumour development (Brouns et al. 2002; 
Johnson 2002). Furthermore, butyrate induces apoptosis in human colon 
cancer cell lines (Avivi-Green et al. 2002). Readily fermentable, soluble 
DF promotes the growth of adenomas in APC Min mice (Oikarinen et al. 
2003; Mutanen et al. 2000), which might suggest that excessive 
production of SCFA may have adverse effects in the animal models, in 
which the apoptosis is already disturbed.  
A high enterolactone concentration has been associated with a high intake 
of vegetables and cereals with antioxidant activity and is considered to be 
a biomarker of their intake (Kilkkinen et al. 2003; Johnsen et al. 2004). A 
higher concentration of plasma enterolactone has been associated with a 
lower risk of acute coronary events (Vanharanta et al. 1999) or with a 
lower risk of breast cancer (Ingram et al. 1997; Pietinen et al. 2001; 
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Adlercreutz 2002). However, enterodiol and enterolactone have less in 
vitro antioxidant activity than their precursor, secoisolariciresinol 
diglucoside (Kitts et al. 1999). When the microbial metabolites of rutin and 
quercetin (3,4-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid) 
were compared with their precursors, the microbial metabolites had more 
anti-platelet aggregation activity and less mutagenicity than their parent 
compounds (Kim et al. 1998; Kim et al. 1996). 
A considerable amount of information is available on the putative 
biological effects of the dietary phenolic compounds present in food. This 
interest in the food components has been promoted by the in vitro 
antioxidative acitivity of the dietary phenolic compounds. However, the 
biological activities are structure-related and when the structure of the 
molecule changes, it is likely that these properties also change. 
1.2 Development of in vitro digestion models 
The in vitro digestion models mimic conditions and luminal reactions 
which occur in the mouth, stomach, duodenum, ileum and colon. The in 
vitro upper intestinal models are used for removal of digestible 
components and for detection of changes in the non-digestible ones. The 
colon model elucidates the role of microbiota in the metabolism of all 
non-digestible parts of the diet, DF and phenolic compounds. Membrane-
bound activities are not taken into consideration in these models. The aim 
of the in vitro digestion models is to characterize and clarify the structural 
changes of food components under physiological conditions, caused by 
alimentary enzymes and by the colonic microbiota, and to obtain 
information going beyond that gained by the chemical analysis of food. 
1.2.1 In vitro enzymatic digestion of starch 
Starch is classified into several classes according to the rate of hydrolysis. 
Resistant starch (RS) is defined as the fraction of starch which is 
fermented in the colon (Englyst et al. 1992). Several methods have been 
adopted for the measurement of RS (Englyst et al. 1992; Berry 1986; 
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Muir and O´Dea 1992; Champ 1992). Enzymatic starch removal is 
performed in DF analyses, in which starch can be removed under non-
physiological conditions for example using Termamyl (a heat-resistant α-
amylase) in a boiling waterbath (Prosky et al. 1992). The sample can be 
gelatinized by boiling prior to the enzymatic digestion at 60°C (Asp et al. 
1983). With each of these methods, gelatinized and solubilized samples 
show a high degree of starch hydrolysis. Another method of DF analysis 
was developed by Englyst and Cummings (1988) using α-amylase 
digestion at 42°C. 
In addition, starch has been removed using several enzymatic in vitro 
batch methods in order to obtain a DF residue for in vitro fermentation 
experiments (Hoebler et al. 1991; Muir and O´Dea 1993; Lebet et al. 
1998). Hoebler and co-workers used Termamyl and a boiling waterbath 
and the starch removal was complete, but during the incubation cell-wall 
polysaccharides were also solubilised possibly due to the high temperature 
used in the assay (Hoebler et al. 1991). Later, a dialysis step was adopted 
to remove the digested components and to retain the soluble fibres in the 
retentate, which was subsequently freeze-dried prior to the in vitro 
fermentation (Lebet et al. 1998). 
Ileal effluents obtained from ileostomy patients have also been used as 
substrates in the in vitro colon models. The ileal effluents and dietary 
fibre isolates showed a similar extent of total SCFA production in 24 h, 
although the extents differred from those of the whole foods (McBurney 
et al. 1988). The metabolizable energy after fermentation of the ileal 
effluents correlated with the corresponding calculated energy values in 
the diets. These studies supported the combined use of the ileal in vivo 
model and the in vitro fermentation model in studies of the energy 
balance of DF (McBurney and Thompson 1989a). However, when the DF 
contents of the samples from ileally cannulated pigs were compared with 
those from in vitro enzymatic digestion, degradation of soluble DF 
components was observed in the in vivo samples but not in those from the 
in vitro treatment (Hoebler et al. 1998). 
A multi-compartmental, continuous, computer-controlled in vitro 
digestion model (TIM-1, TNO gastro-Intestinal Model) simulates the 
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secretion, motility and absorption of the upper intestine (Minekus et al. 
1995). The model includes compartments mimicking the stomach, the 
duodenum and the ileum, and reproduces accurately the pre-set data on 
the transit time, the pH and the bile concentrations, which have been 
obtained from in vivo studies with healthy human volunteers. The model 
has been used for studying the digestion and the absorption of glucose, for 
estimation of the bioavailability of iron and phosphorus, for studies of the 
coagulation and digestion of proteins, and for studies of the survival of 
lactic acid bacteria (Minekus et al. 1995). 
Enteromix® research tools (Danisco) include clinical assays, simulations 
and screening assays. Physiological, microbiological and immunological 
responses to food and feed ingredients can be simulated. These simulation 
models are used for the evaluation of efficient doses of active ingredients 
in the food and feed and for studies of the effect of the food matrix on the 
tested response (www.enteromix.com). 
1.2.2 In vitro colon models  
The in vitro colon models include continuous, semi-continuous and batch 
culture systems, which maintain colonic microbiota, usually obtained 
from human faeces, under strictly anaerobic conditions. The methods 
differ from each other in the structure of the fermentor, substrate-to-
inoculum ratios, media, operating conditions and sampling (Rumney and 
Rowland 1992). Different fermentation methods have been compared in 
different laboratories (Edwards et al. 1996). Media have varied from a 
simple mineral salt solution to a complex medium containing vitamins, 
hemin, SCFA, yeast extract and trypticase, a reducing agent and different 
buffers. The cultures have been static or several mixing methods have 
been used: regular swirling, a shaking water bath or periodic mixing. All 
these variables affect the fermentation of starch and the comparision of 
the results is very difficult (Edwards et al. 1996). 
Different types of colon models can be used for specific purposes. Batch 
cultures are suitable for the studies of microbial metabolism of DF, RS 
and isolated phenolic compounds (Barry et al. 1995; Edwards et al. 1996; 
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Déprez et al. 2000; Heinonen et al. 2001). However, during the incubation 
nutrients are consumed and products are accumulated, causing altered 
culture conditions which may result in a distorted interpretation of 
microbial metabolism in batch cultures at later time points. This can be 
avoided in semi-continuous systems (Campbell et al. 1992). Continuous 
and semi-contiuous systems are also suitable for study of the colonic 
ecosystem and bacteriology (Miller and Wolin 1981; Allison et al. 1989). 
A single-stage continuous system cannot reproduce the heterogeneity of 
physiological conditions and nutrient availabilities that occur at different 
parts of the colon in vivo. However, this reproduction of conditions can be 
achieved in a multi-stage chemostat (Allison et al. 1989). 
Molly and co-workers presented a 5-step multi-chamber reactor as a 
simulation of the human intestinal microbial ecosystem. This so-called 
SHIME model consists of two vessels simulating the duodenum/jejunum, 
and ileum, respectively, and the 3rd, 4th and 5th vessels corresponding to 
the caecum and ascending colon, transverse colon and descending colon, 
respectively (Molly et al. 1993). A three-stage compound continuous 
culture system was investigated in terms of carbohydrate metabolism and 
amino acid metabolism at the University of Reading. Carbohydrate 
breakdown and SCFA production occurred mainly in the first reactor, 
whereas amino acid fermentation producing branch-chain fatty acids 
occurred mainly in the reactors 2 and 3. Thus, the reactions in the three 
reactors corresponded to reactions occurring in the ascending, transverse 
and descending colon in vivo, respectively (Macfarlane et al. 1989; 
Macfarlane et al. 1992; Macfarlane et al. 1998; Probert et al. 2004). 
The latest development of a continuous, anaerobic colon model is a 
computer-controlled in vitro system (TIM-2) with peristaltic mixing, 
water absorption and absorption of fermentation products (Minekus et al. 
1999). When the substrate is passed from one compartment to another 
through the model, the temperature, pH, peristaltic movements, 
absorption of water and the fermentation products are continuously 
monitored and controlled. The model used a high-density complex 
microbiota and it has been used for the fermentation of DF and phenolic 
compounds, for studies of the formation of ammonia, for the investigation 
of probiotic bacteria and for studies of the bioconversion of glucosinolates 
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(Venema et al. 2004). The continuous flow models require high technical 
and scientific expertise and they have high costs in terms of both 
hardware and running expenses. 
The Enteromix® tools also include a small-scale, semi-continuous colon 
simulator. This model consists of four sequentially attached anaerobic 
vessels representing the ascending, transverse, descending and distal colon, 
respectively. All fluid transitions and pH adjustments are computer-
controlled. Because of the small working volumes of the vessels, only a 
small amount of substrate is needed for a 48-hour simulation (Mäkivuokko 
et al. 2005). When valuable isolated compounds are applied to the colon 
model in vitro, it is also relevant to use small batch cultures with adequate 
stirring. Furthermore, this is a simple way of studying accurately the time 
course of formation of the microbial metabolites. 
A European interlaboratory study was performed for testing a simple, 
reproducible batch system for DF fermentation (Barry et al. 1995). The 
inoculum was composed of fresh human faeces mixed with a carbonate-
phosphate buffer supplemented with trace elements and urea. Five 
different carbohydrate sources were compared in five laboratories on 
three occasions in order to determine the pH, residual non-starch 
polysaccharide and SCFA production during the in vitro fermentation. 
The observed interlaboratory differences could be reduced either by 
reducing the amount of substrate or by using a dense inoculum. The 
optimal amount of carbohydrates was 10 g/l in a faecal suspension of 167 
g/l. There was also a close correspondence between the in vitro data and 
an in vivo rat experiment using diets supplemented with the same sources 
of DF (Barry et al. 1995). 
Another interlaboratory study was conducted for quantification of RS. A 
similar amount of fresh human faeces (160 g/l) was suspended to a buffer 
in a batch in vitro fermentation model in order to compare substrates (100 
mg) containing different amounts of total and resistant starch (Edwards et 
al. 1996). The buffer delayed the decrease of pH caused by SCFA 
production. The maximum incubation time was 24 h, which was 
considered to correspond to the transit time through the proximal colon 
(Edwards et al. 1996). 
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1.2.3 Faeces as an inoculum 
The number and the composition of the microbiota vary considerably 
along the human gastrointestinal tract. Due to the low luminal pH the total 
bacterial count in gastric contents is usually below 103 cells/g. In the 
small intestine, numbers of bacteria range from 104 cells/ml in the 
proximal ileum to 106107 cells/ml in the ileocaecal region. The human 
colon typically contains 10111012 cells/ g contents, the majority of which 
are strict anaerobes (Salminen et al. 1998; Kleessen et al. 2000). The 
colon resembles a continuous, anaerobic fermentor with a volume of 500 
ml and with a content of 220 g of digesta. The microbiota are diverse, 
consisting of 400500 different bacterial species, as well as yeast, fungi 
and protozoa, which are poorly quantitated (Conway 1995). In order to 
become established in the intestine, the microbiota must be able to 
multiply at a faster rate than their elimination rate. An acidic environment 
and excessive peristalsis disturb colonisation by the microbiota (Kleessen 
et al. 2000). Colonic microbiota is closely associated with the colonic 
epithelium, preventing the invasion of pathogenic bacteria and interacting 
with the immune system via lymphocytes in the epithelia and mucosa 
(Salminen et al. 1998). 
The most common way of obtaining colonic microbiota is by collecting 
faecal samples, because the use of faecal donors is non-invasive and there 
are no ethical objections (Conway 1995). Obligately anaerobic bacteria, 
Bacteroides spp., Eubacterium spp., Bifidobacterium spp., clostridia, 
lactobacilli, anaerobic cocci and Fusobacterium spp., are detected in high 
numbers in faeces by bacterial culture. In addition, facultative anaerobic 
organisms such as Escherichia coli, enterococci and streptococci are 
commonly encountered. The investigation of colonic microbiota by 
culture-based methods has several limitations. The lack of culture media 
supporting the growth of some components of the dominant microbiota, 
difficulties in the identification by phenotypic methods and continuous 
changes in the taxonomy complicate the studies (Kleessen et al. 2000). 
However, the systematic determination of gut microbiota is now possible 
by high-resolution molecular genetic techniques such as ribosomal RNA 
sequencing (Salminen et al. 1998; Tannock 2001). 
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The enumeration of different microbial species resident in the colon is 
difficult. Selective plating underestimates the abundance of many species 
and new tools have been developed for characterization of the microbiota. 
The isolation of the genome of faecal microbiota and guanin-cytocin 
fractionation (%G-C profiling) together with denaturing gradient gel 
electrophopresis enhance the diversity assessment and detection of 
minority populations of bacteria (Apajalahti et al. 2003; Apajalahti et al. 
2004; Holben et al. 2004). Furthermore, the importance of analysing the 
biological activity of the faecal microbiota in terms of microbial 
metabolites has been emphasized (Conway 1995; Salminen et al. 1998). It 
has been postulated that the microbiota in the feaces has a higher 
similarity to the luminal than to the mucosal microbiota in the colon, due 
to the higher proportion of facultative anaerobes near the mucosa. 
However, since dietary constituents are first encountered by the luminal 
microbiota in vivo, it is relevant and convenient to use the faecal 
microbiota in the in vitro colon model (Rumney and Rowland 1992). 
Although the composition of the bacterial community is an important 
issue, the aims of the present thesis did not include the identification and 
characterization of the faecal microbiota. The target of the present thesis 
was focused on the metabolic activity of the faecal microbiota. 
Individual variation of faecal samples is caused by the age or the diet of 
the donor, by the time of collection of the faeces, by intestinal diseases 
and by medication, especially antibiotics (Conway 1995; Salminen et al. 
1998; Rowland et al. 1999; Kilkkinen et al. 2002). Both intra-individual 
and inter-individual variations of faecal microbiota occur and the 
variations are of similar magnitude independently of their origin (Barry et 
al. 1995). Most bacterial species are capable of several metabolic 
activities. In order to improve the reproducibility of metabolic studies 
using faeces, a pooled faecal sample is required from at least three 
different donors. Thus the metabolic activity can be stabilised by 
diversifying the microbial composition (Weaver et al. 1989; Mortensen et 
al. 1991; McBurney and Thompson, 1989b). In the colon 1500 ml of the 
chyme entering the caecum is reduced to 80200 ml, which is discarded 
as faeces (Guyton and Hall 1996a). From this data the physiological 
concentration of the faecal suspension could be calculated as 513 % 
(v/v) in the caecum. 
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The microbes were not isolated from faecal matter, because a selection of 
the microbiota would occur. Particularly, cultivation increases the relative 
abundance of the facultative anaerobes (Bearne et al. 1990). Furthermore, 
different carbohydrate sources in the in vitro fermentation cause changes 
in the microbiota (Slade et al. 1987). A long incubation time decreases the 
viability of the microbiota due to the severely nutrient-limited conditions 
(Allison et al. 1989). 
Faecal dry matter contains 30 % bacteria, 1020 % fat, 1020 % inorganic 
matter, 23 % protein, 30 % undigested roughage from food and dried 
consituents of digestion fluids and epithelial cells (Guyton and Hall 1996a). 
Faecal matter provides nutrients for the microbial population obtained 
from the donors. The chemical and physical nature of the dense inoculum 
is also closer to that present in the caecum and reduces the need for 
adding components to the medium, such as bile acids and micronutrients, 
which are naturally present in faeces. Therefore, only a simple buffer is 
sufficient as a medium.  
A high inoculum concentration allows the best survival of bacterial 
species, and also produces a lower redox potential and a higher final 
osmolality. However, each inoculum is different and only relative 
comparisons can be made between series (Edwards et al. 1996; Barry et 
al. 1995). Nevertheless, a simple rapid procedure in the preparation of the 
pooled, dense inoculum from several donors can overcome the problems 
of individual variation and the selection of microbiota during the 
incubation in the in vitro colon model. An advantage of a batch model is 
that the same faecal inoculum devoid of substrates can be incubated 
simultaneously and its metabolite profile can be presented as a reference 
to those of the substrates. 
 30 
1.3 In vitro digestion models in relation to 
gastrointestinal physiology, digestion and 
metabolism of phenolic compounds 
The human gastrointestinal physiology, the digestion of carbohydrates 
and the metabolism of phenolic compounds are described in the following 
sections in order to elucidate the choices regarding the reagents, enzymes, 
operating pH values and incubation times of each stage of the in vitro 
digestion models. The sites of the gastrointestinal tract which are 
simulated by the in vitro enzymatic model and the colon model are 
illustrated in Figure 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The sites of the gastrointestinal tract simulated by the developed 
in vitro enzymatic digestion and colon models. 
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1.3.1 Mouth 
The digestion of food starts in the mouth, where teeth grind the plant food 
with a force of 3001000 N (Guyton and Hall 1996a). The disintegrated 
plant matrix contains cell-wall tissue pieces with a large proportion of 
intact cells (McDougall et al. 1996). The hydrolysis of starch starts in the 
mouth, where maltose, maltotriose and α-limit dextrins are formed. 
However, only 5 % of all the starch eaten is hydrolysed by the time the 
food is swallowed (Guyton and Hall 1996c). During mastication the 
principal salivary glands start their secretion of saliva, which ranges daily 
between 800 and 1500 ml. Saliva contains two major types of proteins: 
ptyalin, an α-amylase for starch digestion, and mucin for lubrication and 
surface protection purposes. Saliva also contains a high concentration of 
potassium and bicarbonate and some sodium and chloride (Guyton and 
Hall 1996b). 
The disintegration and starch hydrolysis in the mouth have been simulated 
in digestion models in several ways. In one in vitro digestion procedure 
commercial salivary α-amylase was applied in 20 mM phosphate buffer 
at pH 6.9 in the presence of sodium chloride (Lebet et al. 1998). When the 
availability of starch was measured, authentic saliva was diluted and used 
similarly in the presence of sodium chloride in potassium-sodium-
phosphate buffer (50 mM, pH 6.9) (Björck et al. 1984). Two methods 
applied the mouth stage in vivo prior to in vitro digestion by pepsin and 
pancreatin. Samples were chewed for 15 seconds by human volunteers in 
order to measure the hydrolysis rate of starch and the extent of starch 
hydrolysis for estimation of RS. Several subjects were required in order to 
take into account inter-individual variation of the resulting particle size 
from different subjects (Granfeldt et al. 1992; Muir and O´Dea 1992). 
1.3.2 Stomach 
In the stomach, gastric glands secrete pepsin as pepsinogen, gastrin 
hormone and hydrochloric acid for protein digestion. Hydrochloric acid is 
secreted as a 160 mM solution at pH 0.8. Total daily gastric secretion is 
about 1500 ml (Guyton and Hall 1996b). The in vivo profile measured 
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radiotelemetrically showed the gastric pH to be 1.6 (Gee et al. 1999). 
Pepsinogen is not active until it is in contact with hydrochloric acid and is 
transformed to pepsin, the active protease. The optimum pH for pepsin is 
between 1.8 and 3.5, and there is only little proteolytic activity at pH 5. 
Gastrin stimulates the secretion of enzymes, and active pepsin further 
enhances the activation of pepsinogen. When the acidity of gastric juice 
decreases below pH value 3.0, the stimulation of secretion becomes 
blocked and the stomach is protected from excessive acidity (Guyton and 
Hall 1996b). 
The hydrolysis of starch continues in the stomach for 1 hour and 3040 % 
of starch is hydrolysed to maltose. Salivary amylase activity is inhibited 
by the acid when the pH of the chyme falls below 4.0 (Guyton and Hall 
1996c). Many plant cells burst in the acidic conditions of the stomach due 
to breakage of acid-labile bonds, and polysaccharide residues may be 
released. The solubility of carbohydrates is enhanced and the viscosity of 
the stomach contents increases causing the feeling of satiety (McDougall 
et al. 1996). The movements of the gastric muscles mix and disintegrate 
food further to produce a semifluid chyme with gastric secretions. The 
stomach stores food and regulates the chyme at a suitable rate for 
digestion and absorption (Guyton and Hall 1996a). 
To simulate the conditions in the stomach, the pH was adjusted in both 
the batch and continuous models by addition of hydrochloric acid until 
the pH decreased to 1.52.0. A commercial pepsin preparation was used 
for the hydrolysis of proteins in carbohydrate foods (Muir and O´Dea 
1992; Minekus et al. 1995; Goni et al. 1997; Lebet et al. 1998). The 
effects of the low pH and the presence of enzyme proteins on the 
detection of phenolic compounds were studied by adding hydrochloric 
acid and pepsin (pH 2.0) or a simulated gastric juice containing sodium 
chloride, pepsin and hydrochloric acid (pH 1.2) to the samples (Martinez-
Ortega et al. 2001; Spencer et al. 2000). 
Methods for simulation of the upper intestine have also been adopted for 
the study of phenolic compounds. Malvidin-3-O-glucoside was incubated 
in the presence of procyanidin dimer in darkness under anaerobic 
conditions and an anthocyanin-flavanol adduct was formed at pH 2.0 and 
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3.8 (Salas et al. 2003). Furthermore, proanthocyanidin oligomers were 
hydrolyzed to mixtures of epicatechin monomer and dimer in the gastric 
milieu (pH 2.0) in the absence of enzymes (Spencer et al. 2000).  
Residence time in the human stomach in vivo varies according to the 
particle size (Guyton and Hall 1996a), but incubation times used in the 
different in vitro batch models have been fixed, ranging from 30 min to 2 
hours depending on the method (Muir and O´Dea 1992; Lebet et al. 1998; 
Gil-Izquierdo et al. 2002). In one multi-compartmental dynamic 
continuous model either slow or fast transit time was simulated. The half-
time of the delivery was 35 min and 70 min for the fast and the slow 
transit time, respectively. The pH of the stomach varied from 4.8 to 1.7 in 
120 min. The simulation of both the half-time and the pH were based on 
the in vivo data (Minekus et al. 1995). 
1.3.3 Duodenum and ileum 
In the human body the amount and the characteristics of pancreatic juice 
are determined by the presence of chyme and its food components in the 
upper portions of the small intestine. Pancreatic juice contains proteolytic 
enzymes (trypsin, chymotrypsin, carboxypolypeptidase, elastase and 
nuclease), amylase for starch and glycogen hydrolysis, lipase for neutral 
fat digestion, phospholipases which split fatty acids from phospholipids, 
and cholesterol esterase (Guyton and Hall 1996b). The daily pancreatic 
secretion is approximately 1000 ml. Bicarbonate ions are also secreted in 
order to increase the duodenal pH. Proteolytic enzymes are in an inactive 
form and are activated enzymatically by enterokinase or by active trypsin. 
Pancreatic juice also contains a trypsin inhibitor.  
Bile salts and sodium bicarbonate are secreted into the duodenum from the 
biliary gland of the liver and stored in the gall bladder, which has a volume 
of 3060 ml. The bicarbonate solution increases the volume of the secretion 
and further increases the duodenal pH. The normal daily biliary secretion is 
between 600 and 1200 ml. Most of the bile salts (94 %) are recirculated by 
the enterohepatic circulation. Bile salts have an important role in 
emulsifying fat, in enhancing the digestion by lipase and in the transport of 
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the hydrolysed products through the intestinal mucosa (Guyton and Hall 
1996b). A radiotelemetric measurement has shown that the pH between the 
duodenum and distal ileum is 6.27.9 (Gee et al. 1999). 
Virtually all the available starch is digested within 1530 seconds after 
chyme enters the duodenum and mixes with the pancreatic juice and bile 
(Guyton and Hall 1996c). The particle size of plant foods is reduced and 
the cell-wall polymers are solubilised concomitantly in the ileum 
(McDougall et al. 1996). The membrane-bound enzymes in the ileal 
epithelium, namely sucrase, maltase, isomaltase and lactase, hydrolyse the 
released maltose and small glucose polymers to monosaccharides, which 
are then actively transported through the brush-border membrane with a 
transport mechanism aided by sodium ions. Insulin accelerates the transport 
of glucose to the cells and permits rapid uptake, storage and use of glucose 
especially by muscles, adipose tissue and liver (Guyton and Hall 1996b, c, 
d). Peptidases split small peptides into amino acids and intestinal lipase 
degrades neutral fats into glycerol and fatty acids (Guyton and Hall 1996b). 
Soluble DF increases the viscosity of the digesta and ensures the steady and 
slow absorption of glucose (McDougall et al. 1996). 
When the starch digestion in the duodenum was simulated in batches, the pH 
was adjusted by addition of sodium hydroxide to reach a pH between 5.0 and 
6.9 depending on the enzymes used in the hydrolysis (Muir and O´Dea 1992; 
Granfeldt et al. 1992; Goni et al. 1997; Lebet et al. 1998). The variation of 
the pH was measured in the continuous model. In the duodenal compartment 
the pH was initially 8.0 and it was stabilized during the residence time to 
vary between 6.5 and 7.0 (Minekus et al. 1995). Starch was hydrolysed 
mainly by pancreatin only (Muir and O´Dea 1992; Granfeldt et al. 1992; 
Goni et al. 1997; Lebet et al. 1998), but some models also used 
amyloglucosidase (Muir and O´Dea 1992; Goni et al. 1997). 
When phenolic compounds are consumed in the diet, they are released 
from the matrix after mastication, the released part is absorbed through 
the ileal epithelium and the rest is released, metabolised and absorbed in 
the colon (Figure 4). Absorption is affected by the structure of phenolic 
compounds (glycosylation, molecular weight and esterification) (Scalbert 
et al. 2002). Phenolic compounds can be transported through the 
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epithelium as glycosides by sugar transporters. In the epithelial cells, 
cytosolic β-glucosidase hydrolyzes these glycosides, and aglycones are 
formed after absorption (Figure 5). Aglycones can also be formed in the 
lumen by the action of membrane-bound lactase phlorizin hydrolase 
(LPH) and they are absorbed passively through the epithelium (Scalbert 
and Williamson 2000). 
 
 
 
 
 
 
 
Figure 4. General metabolism of phenolic compounds, modified from 
Scalbert and Williamson (2000). 
Once absorbed, aglycones undergo a conjugation in the ileal epithelium or 
in the liver. Hepatic metabolites (methylated, sulphated or glucuronidated 
conjugates) are returned to the luminal side via bile (enterohepatic 
circulation) (Figure 4) (Nemeth et al. 2003; Scalbert and Williamson 2000). 
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Figure 5. The deglycosylation of phenolic compounds, modified from Day 
et al. (2000). 
The effects of pH and the alimentary enzymes were studied on the structure 
and the detection of phenolic compounds in various in vitro batch models. 
Phenolic compounds have been subjected to the dissolution test according 
to the United States Pharmacopeae using a sodium chloride solution with 
HCl and pepsin in the stomach stage, and sodium hydroxide with 
pancreatin in the duodenum stage (Martinez-Ortega et al. 2001; Goh and 
Barlow 2004). Martinez-Ortega and co-workers (2001) measured changes 
in phenolic compounds in wine in gastric and intestinal media using a 
paddle method for mixing. The digestion of wines increased the 
concentration of gallic acid, caffeic acid, quercetin and catechin, while the 
concentrations of resveratrol, caffeoyltartaric acid and ethyl gallate were 
stable in the gastric and intestinal media. Goh and Barlow (2004) studied 
flavonoid recovery and stability in the digestion of Gingko biloba leaves. 
The digestion increased the recovery of flavonols from the leaves. The 
content of (-)-epigallocatechin gallate was decreased in authentic intestinal 
juice as a consequence of an oxidative dimerization (Yoshino et al. 1999). 
A sophisticated method for liquid samples containing phenolic compounds 
was developed by Gil-Izquierdo and co-workers (2002). The method consisted 
of an initial pepsin-HCl incubation for 2 h at 37°C. A dialysis tube containing 
water and sodium bicarbonate was added to the pepsin incubation, and 
pancreatin with bile salts was added after the pH reached a value of 5. After 
Ileal epithelium
Aglycone Sugar
LPH
transporter
Sugar
Aglycone
Aglycone
 37 
2.5 h at 37°C, the dialysis tube was removed and the dialysate was analysed 
for phenolic compounds (Gil-Izquierdo et al. 2002). Sodium bicarbonite from 
the dialysis tube increased the pH and the phenolic compounds had diffused 
into the tube. Thus the absorption of phenolic compounds was also performed 
in vitro. The method was used in several studies regarding the availability, the 
structural transformations and the effects of industrial processing methods on 
phenolic compounds (Gil-Izquierdo et al. 2001, 2002, 2003; Pérez-Vicente et 
al. 2002; Vallejo et al. 2004). 
The residence time of food in the duodenum and ileum is between 3 and 5 
hours, during which it is digested and absorbed (Guyton and Hall 1996c). 
The simulated residence times in the duodenum stage of the batch 
digestion models varied from 1.5 hours to 23 hours (Lebet et al. 1998; 
Martinez-Ortega et al. 2001; Gil-Izquierdo et al. 2002). When transit 
through the ileum was also included in the model, the incubation time was 
prolonged to 6 hours (Muir and O´Dea 1992). In the continuous digestion 
model, the half-time of the ileal delivery was 85 and 160 min for the fast 
and the slow application, respectively (Minekus et al. 1995). 
1.3.4 Colon 
The colon is divided into the caecum, ascending colon, transverse colon, 
descending colon, sigmoid and rectum. Due to the active absorption only 
about 1500 ml of chyme is emptied from the ileum to the caecum daily 
(Guyton and Hall 1996a). The only secretory function in the colon is the 
mucus secretion with bicarbonate. The epithelial cells contain enzymes 
only in small amounts. Mucus holds the faecal matter together, protects 
the colonic wall from the microbial activity and bicarbonate provides a 
barrier against the acidic metabolites formed by the microbial action in 
the colon (Guyton and Hall 1996b). Radiotelemetric measurements have 
shown that the pH at the ileo-caecal valve is 7.9, but decreases rapidly to 
5.4 in the transverse colon, indicating a rapid formation of acidic 
metabolites (Gee et al. 1999). Study of these conversion reactions is the 
main interest in the in vitro colon model and these aspects are discussed 
in detail in the following sections. 
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The colon also has the two following functions: absorption of water, 
electrolytes and SCFA, and the storage of faecal matter before defecation. 
Sodium absorption occurs by an active transport mechanism and it is 
responsible for the large electrical gradient across the mucosa (Guyton 
and Hall 1996a). 
The saccharolytic microbiota have several hydrolysing enzyme activities. 
Xylanases, arabinanases β-glucanases, galactomannanases, polygalacturonases, 
mucinases and cellulases degrade polysaccharides to oligomers and 
monomers, which are further converted to short-chain fatty acids (SCFA) 
(Salyers and Leedle 1983; Hudson and Marsh 1995; Cummings 1995). 
Gastrointestinal mucus, mucin, is a protective gel-forming glycoprotein 
(Neutra and Forstner 1987), which is also fermented to SCFA by the 
colonic microbiota (Macfarlane et al. 1989). 
During the fermentation of carbohydrates some 40 % of the energy escaping 
digestion can be transformed to an available form by SCFA production 
(Livesey 1995). According to Cummings (1995) SCFA are the major 
products of fermentation in the human colon, arising from dietary and 
endogenous carbohydrates and proteins which reach the large bowel. The 
predominant SCFA found in human colon are acetic acid, propionic acid 
and butyric acid. The minor fatty acid related anions of the human colon 
are formic acid, lactic acid, valeric acid, caproic acid, isobutyric and 
isovaleric acids. Fermentation of different polysaccharides results in 
typical relative proportions of acetate, propionate and butyrate 
(Cummings 1995). The measurements of microbial fermentation products 
from sudden death victims have shown that the products from 
carbohydrate fermentation (SCFA, lactate, ethanol) are formed in the 
caecum and in the ascending colon, and that the concentrations of 
metabolites from protein fermentation (ammonia, branched chain fatty 
acids and phenolic compounds) increase progressively from the right to 
the left colon (Macfarlane et al. 1992). Furthermore, gaseous products, 
hydrogen and carbon dioxide, are formed as primary gases, and methane 
or hydrogen disulphide as secondary gas products, the formation of which 
scavenges hydrogen. Only a certain proportion of human individuals (30-
60 %) are methane producers (Levitt et al. 1995). 
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Those phenolic compounds which enter the colon are unabsorbed 
glycosides, such as quercetin-3-rhamnoglucoside, and conjugates after ileal 
and hepatic metabolism via enterohepatic circulation (Scalbert and 
Williamson 2000). Compounds can also be enclosed in the food matrix and 
thus absorption can be prevented (Nielsen et al. 2003). When compounds 
reach the caecum, they are subjected to the microbial metabolism. Many 
flavonoids undergo ring-fission, in which the B-ring is degraded and 
phenolic acids are formed (Figure 6) (Scalbert and Williamson 2000; 
Scalbert et al. 2002; Rechner et al. 2002; Manach et al. 2004). Butyrivibrio 
sp. C3, Clostridium orbiscindens sp. nov. and Eubacterium ramulus were 
capable of the ring-fission of quercetin, whereas only Enterococcus 
casseliflavus was able to utilize glucose from quercetin-3-glucoside and it 
did not attack the C-ring (Krishnamurty et al. 1970; Winter et al. 1991; 
Schneider et al. 1999). Microbial metabolites are absorbed from the colon 
and are again subjected to the metabolism of the liver resulting in 
glucuronidated and sulphated conjugates (Axelson and Setchell 1981; 
Adlercreutz et al. 1995; Lampe 2003). Microbial metabolites also appear in 
plasma and urine (Sawai et al. 1987; Gross et al. 1996; Kilkkinen et al. 
2003; Juntunen et al. 2000; Nesbitt et al. 1999). Microbial metabolites of 
several flavonoids have been identified either from in vivo animal trials or 
from clinical trials involving human subjects. Furthermore, phenolic 
compounds have been incubated with animal caecal or human faecal 
microbiota. This in vivo and in vitro evidence is collated in Appendix A. 
 
 
 
 
 
Figure 6. The microbial metabolism of phenolic compounds in the colon. 
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Another example of colonic metabolism of phenolic compounds is the 
bioconversion of plant lignans. After their release from the plant matrix, 
plant lignans undergo conversion to enterodiol and enterolactone (Setchell 
et al. 1981; Borriello et al. 1985; Thompson et al. 1991; Heinonen et al. 
2001; Wang et al. 2000; Xie et al. 2003). The involvement of colonic 
microbiota in the conversion was confirmed by a study using germ-free and 
human microbiota-associated rats (Bowey et al. 2003). Secoisolariciresinol 
is converted to enterodiol and enterolactone via several intermediates. 
Pinoresinol and lariciresinol appeared to have a similar metabolism to that 
of secoisolariciresinol and matairesinol. However, syringaresinol and 
isolariciresinol were also suggested to have alternative routes of 
metabolism by human faecal microbiota in vitro (Heinonen et al. 2001). 
Furthermore, synthetic, labelled lignin has been shown to be converted to 
enterolactone in rats (Begum et al. 2004). Lignin is structurally related to 
lignans, but differs from them in its polymeric nature. Only two species 
have hitherto been identified to take part in the metabolism of 
secoisolariciresinol, Peptostreptococcus sp. SDG-1 and Eubacterium sp. 
SDG-2 (Wang et al. 2000). Enterococcus faecalis PDG-1 was responsible 
for biotransformation of pinoresinol diglucoside to (+)-lariciresinol (Xie 
et al. 2003). Thus enterolactone production is a complex phenomenon 
including several putative precursors and intermediary metabolites. 
The amount of substrate is a crucial factor in fermentation studies. There 
is a requirement to maintain the microbiota unchanged in the in vitro 
fermentation. This can be achieved by adjusting the amount of 
carbohydrates to an optimal level and by using a dense faecal inoculum, 
which is less susceptible to changes in the course of fermentation. When 
pure phenolic compounds are introduced to the in vitro fermentation 
model, the molecular weight and the solubility of the substrate compound 
vary according to their degree of conjugation. The more sugar moieties 
are attached, the more soluble are the compounds. Therefore, it is 
important to measure the amount of the substrate on a molar rather than 
on a mass basis. 
The substrate-to-inoculum ratio describes the concentration of the 
substrate in relation to the faecal suspension concentration. Substrate-to-
inoculum ratios in some earlier investigations have been shown to vary 
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from 1.4 to 590 µmol/g fresh faeces (Table 2). The highest ratio was used 
for the identification of minor metabolites and the medium was saturated 
with one phenolic compound (Justesen and Arrigoni 2001). A lower ratio 
than that above was used for the identification of metabolites from 
catechin derivatives by a nuclear magnetic resonance technique (Meselhy 
et al. 1997). Conversion efficiencies cannot be studied when the faecal 
suspension is saturated with the compound under investigation. When 
14C-labelled proanthocyanidins (PA) were used in the study of Déprez et 
al. (2000), only 2.7 % of the 14C-label from the substrate was recovered 
from the metabolites, suggesting other possible routes of degradation. 
Since the inoculum concentration was low, the microbiota may have been 
affected by the substrates. The proposed microbial metabolites from these 
experiments are collated in Appendix A. 
Comparison of conversion efficiencies has been possible with the lowest 
substrate-to-inoculum ratio in the study of enterolactone formation from 
pure plant lignans. Because the substrates were dosed on a mass basis and 
the molecular masses of these plant lignans vary, the substrate-to-
inoculum ratios on a molar basis were slightly different for each 
compound. The inoculum concentration was also high, which meant that a 
high concentration of the rather expensive pure lignans was required 
(Heinonen et al. 2001).  
 42 
Table 2. The substrate-to-inoculum ratios applied for isolated phenolic 
compounds in faecal fermentation experiments in vitro. 
Substrate Substrate 
concentration 
 
µmol/l 
Faecal suspension 
concentration 
 
g/l 
Substrate-to-
inoculum ratio 
 
µmol/g fresh 
faecal matter 
Reference 
Flavonols 
Rutin  
Isoquercitrin 
Quercetin 
 
16 000 
22 000 
30 000 
 
50 
50 
50  
 
320  
440  
600  
(Justesen  
and 
Arrigoni 
2001) 
Condensed 
catechins 
Proanthocyanidin
(PA) as catechin 
unit eq. 
PA polymers 
Labelled PA 
polymers 
 
 
 
 
 
5 000 
 
5 000 
 
 
 
 
 
9.5 
 
9.0  
 
 
 
 
 
530  
 
560  
(Déprez  
et al. 2000) 
Catechins 
(-)-epicatechin 
and its 
galloylated 
derivatives 
1 000 50  20  (Meselhy et 
al. 1997) 
Lignans 
Mat, Seco, Pin, 
Syr, HMR, 
IsoLar, Lar1 
235350  167  1.412.10  (Heinonen  
et al. 2001) 
                                                     
1 Mat: Matairesinol; Seco: Secoisolariciresinol; Pin: Pinoresinol; Syr: Syringaresinol; 
HMR: Hydroxymatairesinol; IsoLar: Isolariciresinol; Lar: Lariciresinol 
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2. Aims of the study 
The overall target of the study was to develop in vitro digestion models 
for mimicking the physiological conditions of the upper intestine and 
microbial conversions in the colon. Furthermore, the aim was to study the 
degradation of plant phenolic compounds in these models. 
The specific aims of the present study were 
• to develop an in vitro enzymatic digestion model for the removal of 
starch prior to the in vitro fermentation of cereal samples (I)  
• to develop and use an anaerobic in vitro faecal fermentation model for 
the bioconversion of pure phenolic compounds in order to identify 
individual microbial metabolites and to follow the time course of their 
formation (II, III) 
• to assess the role of faecal microbiota in the overall metabolism of 
phenolic compounds (II, III) 
• to assess the role of rye matrix in relation to the microbial metabolism 
of plant lignans (IV, V). 
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3. Materials and methods 
Only a summary of the materials and methods used in this work is 
presented here. Detailed information is included in the original 
publications IV. 
3.1 Substrate preparation 
3.1.1 Pure phenolic compounds  
Rutin (quercetin-3-O-rhamnoglucoside) was used in the development of a 
faecal fermentation method for isolated phenolic compounds (II). Rutin 
trihydrate and isoquercitrin (quercetin-3-O-glucoside) were purchased 
from Extrasynthese (France) (II, III). A mixture of quercetin glucuronides 
was prepared as described by O´Leary and collaborators (2000). The 
composition of the quercetin glucuronide mixture was 85 % quercetin-4´-
O-glucuronide, 6.5 % quercetin-3´-O-glucuronide and 6.5 % quercetin-3-
O-glucuronide and/or quercetin-7-O-glucuronide (II). A list of standards 
used in the analyses of the quercetin study is provided (II). 
In order to study the deglycosylation of anthocyanin glycosides and to 
identify microbial metabolites of anthocyanins, cyanidin-3-glucoside 
(Cy3g) and cyanidin-3-rutinoside (Cyrut) were obtained from the skins of 
red plums (Prunus domestica L.). Malvidin-3-glucoside, delphinidin-3-
glucoside, petunidin-3-glucoside and peonidin-3-glucoside were isolated 
from the skins of red grapes (Vitis vinifera L.). The anthocyanins were 
isolated from the plant material by repeated extractions with methanol 
containing 0.1 % HCl, and purified by column chromatography (Silicagel 
60- Polyclar AT; 80:20) and by semi-preparative high-pressure liquid 
chromatography (HPLC) (II). A list of standards used in the study of the 
colonic metabolism of anthocyanins is provided in III. 
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3.1.2 Cereal samples 
The enzymatic in vitro digestion model was developed using alimentary 
enzymes (salivary α-amylase, pepsin, and pancreatin) for the digestion 
and hydrochloric acid, sodium bicarbonate and bile salts for adjustment of 
the pH. The released glucose (response) was illustrated as a three-
dimensional area with contour lines (response surface). Development of 
the enzymatic digestion model was performed using cooked wholemeal 
rye flour (cv. Anna) in the experimental design 1. In the second design 
(experimental design 2) when enzyme concentrations were increased 
response surfaces could not be obtained with cooked rye flour and 
therefore native rye flour was used. The assessment of the model was 
performed using bread samples. The rye bread was commercial, soft, 
wholemeal sourbread containing 20% wheat flour. Wholemeal wheat 
bread and white wheat bread were baked at the VTT test bakery. The 
breads were freeze-dried, milled and sieved (particle size 800 µm) before 
passing through the model. The small particle size was selected to avoid 
the effect of particles on the digestion (I). 
Rye bran and flaxseed meal were donated by Melia Ltd (Raisio, Finland) 
and Elixi Oil Ltd (Somero, Finland), respectively (IV, V). 
Thermomechanical (extrusion) and xylanase treatments were used for the 
partial solubilisation of cell-wall structures to enhance the release of plant 
lignans (IV: Figure 1). After processing all the cereal samples were 
additionally digested in the enzymatic in vitro digestion model. 
The pre-digested rye bran and flaxseed meal were used when the 
supplements for the in vitro colon model were composed. For the rye 
bran-flaxseed (R&F) supplement the amounts of the pre-digested samples 
were fixed to 180 mg of rye bran and 20 mg of flaxseed meal. The DF 
content of the R&F supplement was 96.7 mg/ 200 mg. Rye bran (R) and 
flaxseed meal (F) supplements were standardized to the same DF content 
by addition of pharmaceutical grade cellulose, mimicking the composition 
of the diets consumed by rats in the in vivo model (V). 
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3.2 In vitro digestion models 
3.2.1 Development of the enzymatic digestion model and its 
application to cereal samples  
A pre-treatment method for cereal samples was developed in order to 
obtain a DF residue for the in vitro colon model. The effect of alimentary 
enzymes on the extent of glucose release was also studied (I). The batch 
method was based on a continuous model described by Molly et al. 
(1993). The experimental designs 1 and 2 (I; Tables II and III) were 
developed in order to study the synergistic effects of the alimentary 
enzymes pepsin and pancreatin, and of pancreatin and bile. Enzyme doses 
per 1500 mg cereal sample varied in the first design as follows: salivary 
α-amylase 1040 U; pepsin 0.61.4 mg; pancreatin 1040 mg and bile 
0.40.6 g, and in the second design as follows: pepsin 12 mg, pancreatin 
2575 mg and bile 0.50.7 g. The final enzyme and bile doses were 
adjusted to the following levels: pepsin 2 mg, pancreatin 75 mg and bile 
0.6 g, which allowed the maximal extent of starch hydrolysis (784 mg) 
measured as released glucose. The day-to-day variation of the final in vitro 
method (I; Figure 1) was studied using raw wholemeal rye flour in 12 
replicates on six different days. The 12 replicates were combined and the 
dried residues were analysed for starch, protein and DF contents (I). In the 
assessment of the final procedure, whole meal rye flour, wholemeal rye 
bread, wholemeal wheat bread and white wheat bread were subjected to the 
enzymatic in vitro digestion in triplicate on four different days. The 
insoluble residues of each sample were washed, freeze-dried and combined 
for their characterization in order to avoid day-to-day variation (I). 
In the study of lignan conversion in the in vitro colon model the starch 
and protein contents of rye bran, its fractions and flaxseed were reduced 
by the in vitro enzymatic digestion and the digestion products were 
removed by a dialysis procedure using a CelluSep H1 membrane (cut-off 
10 000; Membrane Filtration Products Ltd, San Antonio, TX, USA) for 
26 hours according to Karppinen et al. (2000). After the dialysis the 
retentates were freeze-dried (IV, V). 
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3.2.2 Development of the in vitro colon model and its 
application to phenolic compounds 
To study the role of faecal microbiota in the metabolism of phenolic 
compounds the in vitro faecal fermentation method according to Barry 
and co-workers (1995) was modified for pure phenolic compounds. The 
in vitro colon model for fermentation of pure compounds is illustrated in 
Figure 7. In order to save the valuable, purified phenolic compounds, 
there was a need to adjust both the inoculum and substrate concentrations. 
Faecal suspensions were prepared under strictly anaerobic conditions 
using faeces from at least four healthy donors as described in the 
publications: In the quercetin study (II) faecal suspension was prepared in 
the buffer (0.11 M carbonate - 0.02 M phosphate) at pH 6.0 (A) or pH 6.9 
(B). Fermentation was performed for rutin in a small batch (10 ml) and in 
a large scale (1000 ml) with pH control (II). To define the optimal 
substrate-to-inoculum ratio the faecal suspension (B; 5 %, w/v) was 
spiked with 0.5, 1.0, 1.5 and 2.0 µmol of rutin in methanol (II). In the 
anthocyanin study (III) two concentrations (5 or 1 %; w/v) of the faecal 
suspension were prepared in the same buffer at pH 5.5 in order to enhance 
the stability of anthocyanin substrates. 
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Figure 7. The in vitro colon model for pure phenolic compounds. 
 
3.2.3 Application of the colon model to lignans within plant 
matrix 
The amount of pre-digested rye bran and its fractions in the fermentation 
model was 100 mg (IV) as recommended by Barry et al. (1995) and 109
200 mg in the rye bran and flaxseed experiment (V: Table 1). A faecal 
suspension was prepared under strictly anaerobic conditions using faeces 
from four healthy donors (IV, V). When rye bran and its fractions were 
subjected to the in vitro colon fermentation model, the inoculum 
concentration was first diluted to 10 % (w/v) to reduce enterolactone 
formation in the faecal background and the time course was followed for 
up to 24 h. The in vitro fermentation was then repeated for pre-digested 
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rye bran using a dense (16.7 %, w/v) inoculum and the incubation time was 
prolonged to 48 h (IV). These conditions were applied when rye bran and 
flaxseed plant lignans were subjected to the microbial conversion (V).  The 
dense microbial population (16.7 %, w/v) was used to avoid changes in the 
microbiota of the inoculum, as recommended by Edwards et al. (1996) and 
to ensure a diverse microbial population for the enterolactone formation. 
The samples were incubated in triplicate in a waterbath at 37°C with 
magnetic stirring (250 rpm) and the time courses of the microbial 
metabolite formation and the consumption of neutral sugars were 
monitored (Figure 3). Results were calculated per 10 ml of the faecal 
suspension. 
3.3 Characterization of the samples 
3.3.1 Alimentary and faecal enzyme activities 
The α-amylase activity in the pancreatin preparation was measured using 
the Ceralpha method of Megazyme (Australia) (I). The extraction was 
made at room temperature at pH 5.2 and the activity was measured at 
40°C for 10 min using p-nitrophenylmaltoheptaoside as a substrate. 
Enzymes needed for the deconjugation of flavonoid glycosides and 
glucuronides were (α, L)-rhamnosidase, (β, D)-glucosidase and (β, D)-
glucuronidase. Enzyme solutions were prepared from the faecal inocula 
(1 % and 5 %, w/v). In the quercetin study faecal microbes from a 5 % 
suspension were washed before the lysis. Thus the specific activities 
represented only the intracellular enzyme activities (II). In the case of 
anthocyanins a 1 % suspension was used and the specific activities 
included both extracellular and intracellular enzymes (III). The cells were 
lysed with lysozyme and the cell debris was removed by centrifugation. 
The susbtrates of the enzyme activity measurements were p-
nitrophenylderivatives and the absorbances were measured at 405 nm (II, 
III). The protein concentration was measured spectrophotometrically 
(Bradford 1976). The specific activities of the enzymes in the faecal 
suspensions were expressed as nmol/min ⋅ mg protein. 
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3.3.2 Cereal samples 
Glucose released in the in vitro enzymatic digestion model was analysed 
by liquid chromatography (LC) with a refractive index detector after 
preliminary acid hydrolysis (I). The contribution of solubilized β-glucan 
to released glucose was considered constant. 
Characterization of the cereal samples was performed as follows: The 
contents of total and digestible starch, β-glucans and fructans were 
detected spectrophotometrically using specific enzymatic kits 
(Megazyme, Ireland). The resistant starch (RS) content was calculated as 
a remainder after subtraction of the digestible starch content from the total 
starch content. Pentosan contents were measured spectrophotometrically 
after acid hydrolysis (Douglas 1981). Contents of soluble and insoluble 
DF were measured gravimetrically in duplicate according to Asp et al. 
(1983). Protein content was analysed with the Kjeldahl method (6.25 x 
nitrogen; Analytica-EBC, 1998) and the content of ash gravimetrically 
after incineration (550°C). Moisture content was determined with a Karl-
Fischer titrator (DL18, Mettler, Switzerland). Analyses were performed in 
triplicate, if not otherwise stated, for rye flour and bread samples (I) and 
in duplicate for rye bran, its fractions and flaxseed meal (IV, V). 
When the performance of the in vitro enzymatic digestion method was 
assessed, the microstructure of the bread samples before and after the in 
vitro enzymatic digestion was investigated by bright-field microscopy.  
The average molecular weights of β-glucan in wholemeal rye bread 
before and after in vitro enzymatic digestion were detected by size-
exclusion-HPLC (SEC-HPLC) using a fluorescence detector (I). 
3.3.3 Phenolic compounds and microbial metabolites 
Rutin, quercetin conjugates and hydroxyphenyl acid metabolites were 
detected with HPLC. The verification of the microbial metabolites of 
quercetin was performed by HPLC with electrospray ionisation-mass 
spectrometry (ESI-MS) (II). Anthocyanins and their metabolites were 
extracted with methanol containing 0.2 % hydrochloric acid and analysed 
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by HPLC with photodiode array spectrophotometric (HPLC-DAS) and 
mass detection (LC-MS) (III). 
Volatile SCFA were measured from faecal suspensions. SCFA were 
extracted with diethyl ether and analyzed by gas chromatography (IV, V). 
The time courses of mammalian lignan and neutral sugar concentrations 
were followed from the freeze-dried samples. Plant lignans from rye bran 
and flaxseed meal (IV, V) were determined by gas chromatography-mass 
spectrometry (GC-MS) (Mazur et al. 1996) with modifications (IV, V). 
Duplicate analyses were carried out for each sample. Mammalian lignan 
contents of the caecal and the ileal contents of rats and from the faecal 
fermentation samples at time points 0, 24 and 48 h were determined as 
presented for the food samples. Mammalian lignans in the fermentation 
samples were analyzed using HPLC with coulometric electrode array 
detection (CEAD) as described by Heinonen et al. (2001). Time-resolved 
fluoroimmunoassay (TR-FIA) was used for analysis of the enterolactone 
concentration from rat plasma after incubation with Helix pomatia 
enzyme mixture. The determination of neutral sugars was carried out by 
DIONEX-HPLC. The extent of metabolite formation was calculated by 
using areas under the curves for enterodiol and enterolactone, for the total 
amount of SCFA (the sum of acetate, propionate and butyrate) and for 
butyrate alone (V). 
3.3.4 Statistical analyses  
All the statistical analyses (V) were performed with the SPSS software 
(SPSS Inc., Chicago, IL). Values for the rat study were expressed as 
median (minimum, maximum) or mean ± SD and values for the in vitro 
fermentation study as mean ± SD. 
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4. Results and discussion 
4.1 Development and application of the enzymatic in 
vitro digestion model 
The main focus of this thesis is on the in vitro colon model. However, when 
the colon model is applied to food containing digestible components, 
enzymatic digestion is required in order to obtain a residue resembling the 
chyme, which enters the colon. Therefore an in vitro enzymatic digestion 
model was developed with special emphasis on starch hydrolysis by the 
means of physiological pH and temperature (37°C) and using an enzyme 
combination as close to the in vivo conditions as possible (I). Although in 
vitro digestion of starch has been studied thoroughly in several ways, the 
effects of pepsin, bile and pancreatin on the extent of starch hydrolysis 
have not been studied previously. Similarly the enzyme concentrations 
have not been varied using an experimental design. 
The variables in the first design were the doses of salivary α-amylase, 
pepsin, pancreatin and bile. Since the contribution of salivary α-amylase 
to starch hydrolysis was small, its dose was fixed (50 U per 1500 mg 
cereal sample) in later experiments and only the doses of the three latter 
enzymes were investigated in the second design. 
The two designs resulted in equations, the coefficients of which described 
the significance of each variable and their possible cross-effects on the 
released glucose. In the first design (I; Table II), the resulting equation I2: 
Glucose (mg) = 1498.9 + 18.5 X  7.1 Y + 2956.2 Z  + 2977.1 Z2 + 1.9 
XY + 12.1 YZ 
showed that the coefficient for the bile dose (2956.2) was high and the 
relative importance of the other terms (-7.1 to 18.5) in the equation was 
                                                     
2 X = pepsin dose (mg/1500 mg sample); Y = pancreatin dose (mg/1500 mg sample); Z = 
bile dose (g/1500 mg sample). 
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small. Synergistic effects of pepsin and pancreatin and pancreatin and bile 
were both positive (1.9 and 12.1, respectively), but not very strong. 
The corresponding equation II3obtained from the second design (I; Table III): 
Glucose (mg) = 82.8 + 164.8 X + 15.3 Y + 32.0 Z  0.1 Y2  2.1XY 
showed that the positive effect of pepsin (coefficient 164.8) on the 
released glucose was higher than those of pancreatin and bile (coefficients 
15.3 and 32.0, respectively) (I; Eq. 2; P < 0.05). 
The influence of pepsin and bile on the extent of starch hydrolysis was 
evident. Pepsin degraded the protein matrix, which enhanced the starch 
availability for its hydrolysis by pancreatin. The result was in agreement 
with that of Holm et al. (1985), who showed that starch hydrolysis of 
wheat samples was substantially enhanced by pepsin. The effect of 
pancreatin concentration on the extent of starch hydrolysis was 
pronounced only when sufficient amounts of emulsifying bile salts were 
present, which may have increased the interaction between starch and 
pancreatin. 
The fit of the model (R2) desribes how well the calculated values obtained 
from the equation fit to the measured responses. In the determination of 
the predictivity of the model (Q2) each point of the response surface is 
predicted using the response of the other points of the response surface. 
The fit and the predictivity of the model in the second design were high 
(0.96 and 0.93, respectively). The difference between measured and 
predicted amounts of released glucose was within the limits of ±2×RSD 
(35.1 mg) with 95 % probability. Pepsin, bile and pancreatin 
concentrations were finally set to 2 mg, 0.6 g and 75 mg per 1500 mg 
cereal sample, respectively. Day-to-day variation of the digestion 
procedure was very low (less than 1.5 %) when measured as residual 
                                                     
3 X = pepsin dose (mg/1500 mg sample); Y = pancreatin dose (mg/1500 mg sample); Z = 
bile dose (g/1500 mg sample). 
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starch content in the native digested rye flour in the second design. 
Standard deviation between predicted and measured values (RSD: 17.6 
mg) was smaller than sample-to-sample standard deviation (STD: 21 mg).  
When the developed method was assessed with whole meal rye flour, 
whole meal rye and wheat breads and white wheat bread, 511 % of total 
starch remained in the residue (I; Table VI). Several values can be found 
in the literature for the amount of residual starch after digestion in the in 
vivo ileostomy model: 3 and 12 % for hot and cold potato starch, 
respectively (Englyst and Cummings 1987), 2.5 % for white wheat bread 
(Englyst and Cummings 1985), and 10 and 8 % for white and wholewheat 
breads, respectively (Wolever et al. 1986). Furthermore, when residual 
carbohydrates were measured as the amount of hydrogen in the breath of 
ileostomy patients after consumption of starchy foods, residual starch was 
very similar: 11% for white bread and 8 % for wholewheat bread 
(Wolever et al. 1986). Cummings and Englyst compared the estimation of 
RS surviving the digestion of several foods by two methods: studying 
starch content from ileal effluents and using the hydrogen breath test for 
healthy subjects. In conclusion, it was estimated that 10 % of all the 
digested starch in Western diets is resistant to hydrolysis in the upper 
intestine (Cummings and Englyst 1991). Thus the in vitro enzymatic 
digestion model used in the present study was able to mimic the extent of 
starch hydrolysis in the in vivo data obtained from the literature. 
A high extent of starch removal (8995 %) was observed in this study. 
This could partly be due to the small particle size (800 µm) of the samples 
and the actions of bile and pepsin (I). In the methods measuring the 
hydrolysis rate of starch, the pancreatin concentrations are rather low, 
which results in a varying extent of starch hydrolysis (2080 %) 
depending on the source of starch (Snow and Dea 1981; Björck et al. 
1984; Goni et al. 1997; Granfeldt et al. 1992). Hoebler and co-workers 
(1991) used proteolytic enzymes at 50°C, thermostable α-amylase at 100°C 
and finally amyloglucosidase at 60°C, and obtained 8491 % starch 
hydrolysis. In the present study the optimization of the enzyme 
concentrations could have contributed to an even higher extent of starch 
hydrolysis using physiological temperature and concomitant actions of 
enzymes and bile, similarly to the conditions in human digestion. 
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In the present study the bread samples were studied by microscopy before 
and after in vitro enzymatic digestion. Residual starch was partly in 
ungelatinized starch granules and partly enclosed in the cell wall matrix (I, 
Figures 4ah). The hydrolysis of cereal starch granules starts from the 
specific susceptible zones (Gallant et al. 1992), which can be observed as 
holes in the centre of the ungelatinized starch granules (I; Figures 4b and 4f). 
When the extent of starch hydrolysis is maximized, the further hydrolysis 
should occur in the slowly digestible starch, because readily digestible 
starch is rapidly hydrolysed and in the remaining starch fraction RS 
should not be susceptible to further hydrolysis at all. Thus it could be 
assumed that the amount of RS would be constant before and after 
digestion. However, 1500 mg of wholemeal rye bread sample contained 
33 mg RS before digestion and its residue after in vitro digestion 
contained only 5.6 mg RS per 1500 mg original sample. Similarly, 1500 
mg of white wheat bread sample contained 10 mg RS and after digestion 
its residue contained only 2.7 mg RS per 1500 mg original sample. Cell-
wall matrix swelled in the digestion procedure and a part of RS might 
have become more available for the hydrolysis. Thermostable α-amylase 
at 95°C was used in the starch assay. Crystalline starch resists the 
hydrolysis, but high temperature results in porous, swollen and 
gelatinized granules with an increased susceptibility to amylolysis 
(Gallant et al. 1992; Colonna et al. 1992). This may have reduced the 
amount of RS after digestion. The results presented here also indicate that 
the starch categories are specified by the method of analysis. 
When the DF contents of the residues were analysed from wholemeal rye 
and wheat breads after centrifugation, 84% and 75 % of the soluble DF, 
respectively, was lost (I; Table VI). The loss was observed as decreased 
amounts of pentosan (71 %) and β-glucan (83 %), especially in the 
wholemeal rye bread (I; Table VI). Furthermore, the average molecular 
weight of β-glucan increased from 190 000 in wholemeal rye bread to 
260 000 in the corresponding residue after digestion and the lost β-glucan 
(MW 50 000) was observed in the supernatant (I; Figure 5). Of the 
original β-glucan and pentosan 99 % and 98%, respectively, were retained 
in the residue after digestion and dialysis (Karppinen et al. 2000; Lebet et 
al. 1998). Therefore the dialysis step was used later in this work for 
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removal of digested components of rye fractions, rye bran and flaxseed 
meal (IV, V). 
During the assessment of the enzymatic in vitro digestion model, 1025 % 
of protein remained in the residues of wheat and rye breads (I; Table V). 
Although complete removal was not achieved, degradation of the protein 
matrix was observed (I; Figure 4ah). The method was applied to the pre-
treatment of rye bran and flaxseed meal prior to the in vitro fermentation 
model (V). The residual protein content in the combined rye bran and 
flaxseed (R&F) supplement was 14.4 % (V, Table 3), the fermentation of 
which resulted in 60 µmol of branched chain fatty acids of 200 mg sample 
per 10 ml batch by the faecal microbiota in 48 h. In the same sample the 
production of acetate, propionate and butyrate derived from carbohydrates 
was 1520 µmol per 10 ml batch. Thus the amount of branched chain fatty 
acids was negligible. 
4.2 Development and application of the in vitro colon 
model to metabolism of phenolic compounds 
4.2.1 Substrate-to-inoculum ratios 
The in vitro fermentation models have been widely applied to 
measurements of the rate and extent of carbohydrate fermentation. 
However, the microbial metabolism of phenolic compounds has not 
received similar attention. The development of modern analytical 
methods has made the application of the in vitro colon model relevant 
again and has enabled quantitative measurement of the metabolites. As a 
consequence, the in vitro colon model was applied to the present study. 
However, the method designed for the study of the carbohydrate 
fermentation needed adjustment of the substrate and the inoculum 
concentrations to ensure detection of the microbial metabolites from the 
faecal suspension, which contains the same metabolites at low 
concentrations. An additional benefit of finding a suitable substrate-to-
inoculum ratio was to save valuable pure compounds and to ensure the 
solubility of the compounds in the medium. Several substrate-to-inoculum 
ratios were used in the present thesis for the quercetin derivatives, 
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anthocyanins and plant lignans from rye bran, from its preparations and 
from flaxseed meal. 
The faecal suspensions were prepared under strictly anaerobic conditions 
by pooling fresh faeces from at least four healthy donors. A special 
emphasis was put on the protection of the faecal microbiota from oxygen 
over the period from donation to the end of the incubation in the in vitro 
model. The viability of the obligate anaerobic microbiota had been tested 
previously in a carbohydrate fermentation study, in which the number of 
anaerobes (1091010 cells/ g) exceeded the number of aerobes (106107 
cells / g) after 4 hours of incubation (Karppinen et al. 2000). The inocula 
in the present study were prepared using the same method. 
Rutin was chosen as a model substrate, because it is a stable compound 
and commercially available. It is also considered to be one of the 
quercetin derivatives reaching the colon due to its rhamnoglucoside 
moiety (Scalbert and Williamson 2000). The suitable substrate-to-
inoculum ratio for pure phenolic compounds was found by diluting the 
faecal suspension to 5 % (w/v), which is within the limits of physiological 
caecal concentrations (513 %) (Guyton and Hall 1996a). The suspension 
was later spiked with rutin (5200 µM). A rutin concentration of 100 µM 
was chosen, because it was high enough to be detected from the 
background and clearly below the saturation point of rutin (205 µM; 
Budavari et al. 1996; II). Thus, some selection of microbiota must have 
occurred during the incubation with rutin, because the background 
metabolite levels were slightly lower in the samples containing rutin (II; 
Fig. 3b). Phenolic compounds have antimicrobial properties (Puupponen-
Pimiä et al. 2001). It is important to use the compounds at low 
concentrations so as not to suppress the activities of the microbiota. The 
same substrate concentration (100 µM) and different inoculum 
concentrations were used for the studies of anthocyanins: 1 % was used 
for the deglycosylation of cyanidin glycosides and 5 % for the detection 
of microbial metabolites (III). 
Rye bran was processed with cell-wall degrading enzymes and soluble 
and insoluble residues were obtained. A faecal suspension concentration 
of 10 % (w/v) was applied for the rye bran preparations in order to 
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decrease the amount of enterolactone background and the same 
concentration was compared with a 16.7 % (w/v) suspension 
concentration in the fermentation of rye bran (IV). Since enterolactone 
concentration was higher (20 nmol) using the 16.7 % faecal suspension 
than when using the 10 % suspension (13.5 nmol) (IV: Figure 5b), the 
higher concentration 16.7 % was applied in further studies with rye bran 
and flaxseed meal (V). 
A substrate dose of 100 mg per 10 ml of faecal suspension is optimal for 
studying SCFA formation from carbohydrates (Barry et al. 1995) and this 
dose was also applied to the fermentation of rye bran fractions. The plant 
lignan contents of rye bran and its preparations were rather low (3.224.6 
nmol per 100 mg of sample; IV). It was speculated that enterolactone 
formation could be enhanced by increasing the amount of plant lignans in 
the substrate dose. Thus the amount of rye bran was increased to 180 mg 
per 10 ml of faecal suspension in rye bran and flaxseed meal (R&F) and 
rye bran (R) supplements (V). The area under the curve of the 
enterolactone formation for R supplement (740±4 nmol×h) was lower 
than that for the feacal background (1520±70nmol×h), indicating either 
that the level of plant lignans in the pre-digested rye bran susbtrate was 
still too close to the faecal background to be detected, or that the 
formation was suppressed (V; Figure 1B). Thus flaxseed (20 mg per 10 
ml of faecal suspension) served as the main source of plant lignans in the 
R&F and flaxseed (F) supplements and rye bran mainly as the source of 
the rye bran matrix for the R and R&F supplements. 
Substrate-to-inoculum ratios used in all the experiments of this thesis are 
presented in Table 3. These results indicated that metabolites are 
detectable from the faecal background if the substrate-to-inoculum ratio is 
between 0.210 µmol phenolic compounds per gram fresh faeces (IIV). 
The enterolactone formation in 24 hours was 18 nmol per 10 ml of faecal 
suspension for the pre-digested and dialysed rye bran extract, and 14 nmol 
per 10 ml for the faecal suspension alone. Thus the substrate-to-inoculum 
ratio for the pre-digested rye bran extract (0.025 µmol phenolic 
compounds per gram fresh faeces) was the smallest ratio still showing the 
enterolactone formation from the faecal background (IV). 
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Table 3. The substrate-to-inoculum ratios used in the different experiments. 
Reaction  
Substrate 
Substrate 
concentration 
 
µmol/l 
Inoculum 
 
 
g/l 
Substrate-to-
inoculum ratio 
 
µmol/g fresh 
faeces 
Reference 
Deglycosylation 
Rutin 
Cyanidin-3-rutinoside 
and -glucoside 
 
100 
 
100 
 
10 
 
10 
 
10 
 
10 
 
(II) 
 
(III) 
Ring-fission  
Rutin and isoquercitrin 
Cyanidin-, 
Delphinidin-, 
Petunidin-, 
Pelargonidin- and 
Malvinidin-3-
glucoside  
Quercetin 
glucuronides 
 
100 
100 
100 
100 
100 
100 
 
 
20 
 
50 
50 
50 
50 
50 
50 
 
 
50 
 
2 
2 
2 
2 
2 
2 
 
 
0.40 
 
(II) 
(III) 
(III) 
(III) 
(III) 
(III) 
 
 
(II) 
Plant lignan 
conversion 
Rye bran 
 
Rye bran extract 
Supplements: 
Rye bran (R) 
Flaxseed (F) 
R&F 
 
 
1.17 
1.17 
2.46 
 
2.19  
39.5  
41.7  
 
 
167 
100 
100 
 
167 
167 
167  
 
 
0.007 
0.012 
0.025 
 
0.013  
0.24  
0.25  
 
 
(IV) 
(IV) 
(IV) 
 
(V) 
(V) 
(V) 
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4.2.2 Deconjugation of flavonoids 
A deconjugation is the first step in the microbial bioconversion of 
phenolic compounds in the colon. In the deconjugation both glycosides 
and ileal or hepatic glucuronides are transformed to corresponding 
aglycones, which are further metabolised in the colon. In a previous 
unpublished study faecal suspension (5 %, w/v) was incubated with rutin 
to determine whether deconjugative enzymes (α,L-rhamnosidase, β,D-
glucosidase, β,D-glucuronidase) were inducible. Bacteria were isolated 
from the faecal suspension, cells were disrupted with lysozyme as 
desribed in (II) and the cell debris was removed. The specific activities of 
α,L-rhamnosidase, β,D-glucosidase, β,D-glucuronidase were 1.0, 6.28.0 
and 2.02.7 nmol/min ⋅ mg protein, respectively, and they were rather 
stable during incubation from 0 to 4 hours in the in vitro colon model. 
The small changes in the specific activities at different time points were 
due to the changes in the protein concentrations and not due to the 
changes in enzyme activities (unpublished data).   
Rutin was deglycosylated completely in 60 min by α,L-rhamnosidase (1.2 
nmol/min ⋅ mg protein) and β,D-glucosidase (6.2 nmol/min ⋅ mg protein). 
Rutin was deglycosylated at a slower rate (within 60 min) than 
isoquercitrin (quercetin-3-glucoside; within 20 min). The low specific 
activity of α,L-rhamnosidase explained the slower deglycosylation of 
rutin. In the deglycosylation of isoquercitrin only β,D-glucosidase activity 
was required. A transient appearance of quercetin aglycone was observed 
(II; Figure 2). The mixture of quercetin glucuronides was deconjugated 
within 10 min by β,D-glucuronidase (2.0 nmol/min ⋅ mg protein). Thus all 
quercetin derivatives were rapidly deconjugated, but the rate was 
dependent on the moiety attached to the aglycone (II). The specific 
enzyme activities of the cell-free extract from the isolated bacteria 
reflected the in vitro deconjugation rates of phenolic compounds by faecal 
suspension. 
Since the deconjugation of quercetin derivatives was rapid using the 5 % 
(w/v) faecal suspension (II), the inoculum concentration had to be diluted 
to a 1 % (w/v) faecal suspension for the study of deglycosylation of 
anthocyanins, cyanidin-3-rutinoside and cyanidin-3-glucoside. The 
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deglycosylation of rutin was repeated and used as a reference. Initial 
concentrations of the added pure phenolic compounds were 100 µmol/l. 
The deglycosylation of cyanidin-3-glucoside was faster than that of 
cyanidin-3-rutinoside and cyanidin aglycone was identified as one of the 
microbial metabolites (Cy-1). Rutin was also deglycosylated at a slow 
rate and quercetin aglycone appeared concomitantly. The heat-inactivated 
suspension did not deglycosylate any of the flavonoids under 
investigation (III; Figures 3 and 5). The specific activities of the bacterial 
enzymes in 1 % faecal suspension were low: 0.23±0.05 and 0.63±0.09 
nmol/min ⋅ mg protein for α,L-rhamnosidase and β,D-glucosidase, 
respectively, and they were in accordance with the hydrolysis rates of the 
corresponding glycosides shown in the in vitro colon model. The lysed 
faecal enzyme solution included both intra- and extracellular enzyme 
activities, because microbial cells were not washed prior to the lysis. The 
1 % faecal suspension was too dilute to allow isolation of the microbes 
from the suspension. 
4.2.3 Ring-fission of quercetin 
The aim of the application of the anaerobic in vitro colon model for pure 
phenolic compounds was to identify and quantitate their microbial 
metabolites and to assess the role of the faecal microbiota in the overall 
metabolism of phenolic compounds. The microbial metabolites of 
quercetin were confirmed and the time course and the extent of ring-
fission were studied (II). The microbial metabolites of quercetin were 
identified as 3,4-dihydroxyphenylacetic acid, the primary C-ring-fission 
product, and its dehydroxylation product: 3-hydroxyphenylacetic acid 
(Figure 8). These metabolites are derived from the B-ring and from the 
remnants of the C-ring (Hollman and Katan 1998). Phloroglucinol, an A-
ring metabolite, detected from the incubations with pure colon bacteria 
(Krishnamurty et al. 1970; Winter et al. 1991; Schneider et al. 1999) was 
not detected from the freeze-dried faecal samples with the complex 
microbiota. Another proposed colonic metabolite, 4-hydroxy-3-
methoxyphenylacetic acid, was detected from the faecal background and 
from samples with rutin, which indicated that the methylated product 
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originated from the donors (II). Hollman and Katan (1998) suggested O-
methylation to occur in the liver after microbial metabolism of quercetin. 
The same metabolites, including the methylated one, have been identified 
from in vivo samples (Appendix A: Table 2). Sawai and co-workers 
(1987) reported that human serum concentrations of quercetin metabolites 
increased 4 to 8 h after oral intake, reached a maximum level at 8 to 12 h 
and returned to the baseline between 20 and 35 h after the oral dose. The 
same metabolites were also identified from human urine (Gross et al. 
1996). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. In vitro formation of quercetin metabolites by human faecal 
microbiota. 
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The maximum concentration of 3,4-dihydroxyphenylacetic acid was 
observed 2 hours from the start of the incubation, after which it decreased 
steadily and the concomitant appearance of 3-hydroxyphenylacetic acid 
was observed. The conversion was completed within 8 h (II; Figure 3a). 
Maximally 60 % of the initial amount of rutin (100 µM) was converted to 
the microbial metabolites during the anaerobic fermentation in vitro. 
Other alternative routes of degradation could also explain the low recovery 
of the metabolites. A substantial part (23.081.1 %) of the radio-labelled 
quercetin was recovered as carbon dioxide (Walle et al. 2001), part of 
which may have come from the quercetin and part from the phenylacetic 
acids. Schneider and co-workers (1999) observed that quercetin or its 
metabolites may be degraded to acetate and butyrate. According to Sawai et 
al. (1987), side chains of 3,4-dihydroxyphenylacetic acid may also be 
shortened to 3,4-dihydroxytoluene. In conclusion, the aims of identification 
of the microbial metabolites of quercetin and assessment of the role of the 
faecal microbiota in its metabolism were partly achieved. 
4.2.4 Microbial metabolites of anthocyanins  
When the microbial metabolism of anthocyanins was studied (III), two faecal 
suspension concentrations (1 % and 5 %, w/v) were used: cyanidin-3-
glucoside and cyanidin-3-rhamnoglucoside were subjected to 1 % (w/v) 
feacal suspension and malvidin-, delphinidin-, petunidin-, peonidin- and 
cyanidin-3-glucoside and cyanidin-3-rutinoside were subjected to 5 % (w/v) 
faecal suspension. Finally, the extent of metabolite formation was studied in 
reference to the amount of the substrate at the intial time point (III). 
Four metabolites were found from the incubations of cyanidin-3-
glucoside and cyanidin-3-rutinoside. Cy-1, cyanidin aglycone, and Cy-2, 
protocatechuic acid (3,4-dihydroxybenzoic acid), were identified by 
comparing the UV-visible spectrum and elution characteristics with 
phenolic standards of the putative metabolites (III). A third metabolite 
(Cy-3), was possibly a phenoxyacid or a phenoxyaldehyde. However, no 
mass spectra were obtained for Cy-2 and Cy-3 due to the mild ionization 
conditions used. Furthermore, the fourth metabolite (Cy-4) was detected 
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after 2 h of incubation using 1 % faecal suspension, and as the only 
microbial metabolite when the suspension concentration was 5 % (w/v) 
(III). The microbial metabolites of cyanidin glycoside are illustrated in 
Figure 9. 
 
 
 
 
 
 
 
 
 
Figure 9. Formation of metabolites from cyanidin aglycone by human 
faecal microbiota in vitro. X: an unknown moiety of 85 mass units. 
Cy-4 was 85 mass units larger than the cyanidin aglycone. A similar 
molecular mass difference was also detected as in the case of the 
metabolites of 3-glucosides of delphinidin, petunidin, pelargonidin and 
malvidin. It could be assumed that the metabolite was the product of a 
conjugation of the aglycone with a moiety containing either sulphur or 
nitrogen. A sulphate conjugation is possible due to arylsulphotransferases 
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present in the faecal microbiota, as has been shown for phenolic 
antibiotics by human intestinal bacteria (Kim et al. 1992). A structural 
transformation involving nitrogen was also considered, because 
harpagoside, an iridoid (a monoterpenoid lactone), was reported to 
undergo replacement of oxygen with nitrogen in the aromatic ring either 
by the human faecal microbiota or by the action of β-glucosidase in the 
presence of ammonia (Harborne et al. 1999; Baghdikian et al. 1999). Both 
β-glucosidase and ammonia can be present in the colon contents, as the 
activity of the enzyme was detectable from the suspensions used in this 
thesis and ammonia can be formed from undigested proteins by the 
colonic microbiota (Macfarlane and Macfarlane 1995). 
Different metabolite profiles were observed using the 1 % and 5 % faecal 
suspensions in the bioconversion of cyanidin-3-rutinoside (III, Figures 8A 
and B). In the 1 % faecal suspension, cyanidin aglycone (Cy-1) appeared 
transiently and protocatechuic acid (Cy-2) was the major metabolite. The 
amount of the phenoxyacid or of the aldehyde (Cy-3) increased steadily 
during the 2 h incubation and the cyanidin conjugate (Cy-4) began to 
appear after 90 min. The latter was the only detected metabolite using the 
5 % faecal suspension or incubation times longer than 2h for the samples 
with the 1 % faecal suspension. 
The concentrations of the microbial metabolites were estimated from the 
amount of substrate, cyanidin-3-rutinoside, detected at the initial time 
point from the corresponding faecal suspensions. The extent of microbial 
metabolite formation was less than 5 µM. It should also be noted that the 
concentration of cyanidin-3-glucoside derived from the deglycosylation 
of cyanidin-3-rutinoside did not exceed 7 µM and that it was quantitated 
by reference to a standard and not estimated from the amount of substrate 
(III; Fig. 4). 
The low recovery of the microbial metabolites may have been caused by an 
underestimation of the initial amount of anthocyanins, as they may have 
been bound to the faecal matrix. The faecal suspension concentration of 
5 % (w/v) resulted in a low recovery of substrates (4266%). The average 
recovery of the substrate from the 1 % active faecal suspension was 75 % 
and 83 % for cyanidin-3-glucoside and cyanidin-3-rutinoside, respectively. 
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Anthocyanin aglycone can open spontaneously to a chalcone structure in 
neutral or mildly basic solutions. Colourless pseudobases and chalcones 
are already the dominating forms of anthocyanins at pH values 5.55.8 
(Clifford 2000a; III). In the anthocyanin study, the initial pH of the buffer 
was 5.5. The addition of faeces to the buffer resulted in a faecal 
suspension with a pH of 5.75, which was lower than that used in the 
quercetin study. The pH equilibrium may have caused underestimation of 
the concentration of the substrate anthocyanins at the initial time point 
(0 hour). 
Furthermore, alternative routes of metabolism are possible. Anthocyanins 
may be converted to carbon dioxide or SCFA by a complete degradation 
of either the C6-C3-C6 skeleton or the microbial metabolites, as was 
earlier shown for quercetin (Walle et al. 2001; Schneider et al. 1999). 
In conclusion, the aim of the identification of anthocyanin metabolites 
was only partly achieved. The extent of the microbial conversion of 
anthocyanins was substantially lower than that shown for quercetin 
derivatives. However, the overall metabolism of anthocyanins is largely 
unknown and protoctechuic acid, as the microbial metabolite of cyanidin, 
has not been reported before. The identification of even a single microbial 
metabolite elucidates the possible route of the overall metabolism and 
may also facilitate studies of bioconversions in vivo. 
Protocatechuic acid has been reported to have anti-oxidative and anti-
inflammatory characteristics and it blocks stress signal transduction. The 
intake of protocatechuic acid decreased tert-butylhydroperoxide-induced 
lesions in the rat liver in vivo. A histopathological evaluation revealed that 
hepatocyte swelling, leukocyte infiltration and necrosis were all reduced. 
Protocatechuic acid also inhibited tert-butylhydroperoxide-induced tyrosine 
phosphorylation, implying activation of a stress signal pathway, in the rat 
liver (Liu et al. 2002b). Furthermore, protocatechuic acid in concentrations 
of 500 and 1000 ppm has been able to inhibit cell proliferation in vivo 
induced by carcinogens in the colon and liver in rats (Tanaka et al. 1993 
and 1995). Protocatechuic acid can be formed in the colon, it can be 
absorbed through the intestinal epithelia and it can be transported to the 
liver for further metabolism as reported for many phenolic compounds 
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(Scalbert and Williamson, 2000). Thus protocatechuic acid could be found 
at sites where it could exhibit the chemopreventive properties mentioned 
above. 
4.2.5 Enterolactone formation from plant lignans 
Rye bran was extruded and fractions were prepared by hydrolysing the 
cell walls by xylanase and isolating the soluble rye bran extract and its 
residue. Extruded rye bran, its hydrolysate, rye bran extract and its residue 
were compared in terms of the enterolactone formation. The enterolactone 
formation was studied in the in vitro colon model after subjecting the rye 
bran products to the in vitro enzymatic digestion procedure (IV). 
Furthermore, the suitability of the in vitro fermentation model for 
prediction of the enterolactone formation was assessed by comparing the 
approaches of the in vitro colon model and an in vivo rat model. Rye bran 
(R), flaxseed (F) and their combination (R&F) were introduced into the 
two models (V). The influence of the rye bran matrix on the conversion of 
plant lignans to enterolactone was discussed (IV, V). 
It was easier to distinguish the intermediary enterodiol formation of rye 
bran from that of the faecal background using the 10 % faecal suspension 
than using the 16.7 % faecal suspension, (IV; Fig. 5a). In the experiments 
with quercetin derivatives and anthocyanins, it was possible to show the 
intermediary steps in the microbial metabolism of phenolic compounds by 
diluting the inocula (II, III). However, rye bran lignans were converted to 
enterolactone to a higher extent (up to 20 nmol) using a 16.7 % faecal 
suspension concentration and a longer incubation time than using a 10 % 
faecal suspension (14 nmol) for 24 h (IV; Fig. 5b). Thus dense suspension 
concentration and a maximum duration of 48 h were also applied in the 
incubations of rye bran and flaxseed samples (V). 
The enterolactone production was found to be a steadily proceeding slow 
process in all the experiments (Figure 10; IV: Fig. 4b and 5b; V: Fig. 1B) 
as compared with the production of enterodiol (Figure 10; IV: Fig. 4a and 
5a; V: Fig. 1A) or the bioconversions of flavonoids (II: Fig. 3a; III: Fig. 
8). This result is supported by the findings of Kilkkinen and co-workers 
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(2001), who found a positive association in men between the serum 
enterolactone concentration and constipation, and by those of Johnsen and 
co-workers (2004), who showed that frequent bowel movements in 
women had a negative effect on the plasma enterolactone concentration. 
Human subjects with long colonic transit time may have more time to 
convert plant lignans to enterolactone than those subjects whose colon 
motility is very active and the subsequent transit time of the colonic 
contents is shorter. 
 
Figure 10. In vitro formation of enterodiol and enterolactone from 
flaxseed secoisolariciresinol (Seco) by the 16.7 % (w/v) human faecal 
suspension (10 ml). 
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When rye plant lignans were released enzymatically by cell wall- 
degrading xylanase, the xylanase hydrolysed the arabinoxylan backbone 
and released phenolic compounds from rye bran. Especially the plant 
lignan conversion from pre-digested soluble rye bran extract was 
enhanced by these treatments. Maxima of enterodiol formation in 10 ml 
samples were 16 nmol, less than 10 nmol and 4 nmol for rye bran extract, 
other rye fractions and for the faecal background, respectively. Maxima of 
enterolactone formation in 10 ml samples were 18 nmol for rye bran 
extract, 13.514 nmol for native rye bran before and after the extrusion 
and for the faecal background, and 78 nmol for xylanase-treated rye bran 
and insoluble rye bran residue. When plant lignans were in the presence 
of either intact or xylanase-treated rye bran matrix, plant lignans were 
converted in vitro to enterodiol, but enterolactone formation in 24 h was 
suppressed (IV: Figures 4a and 4b). There may have been a suppressing 
component in the rye bran matrix, which was retained in other fractions 
than the rye bran extract. Especially, the dialysis after the enzymatic 
digestion in vitro could have removed some soluble rye bran components 
from the extract, because suppression of enterolactone formation was not 
observed in the dialysed extract. The suppression was also observed in the 
in vitro fermentation experiment with rye bran (R) supplement, the 
enterodiol and enterolactone formations of which were below those of the 
faecal background (V). 
In the in vitro colon model the highest enterodiol concentration in a 10 ml 
sample of the R&F supplement reached 220 nmol in 12 hours, whereas 
enterodiol formation from the F supplement was only 120 nmol in 68 
hours. The enterolactone formation occurred steadily for 36 hours in both 
the supplements containing flaxseed, but there was a huge difference in 
the enterolactone concentrations reached at the end of the incubation 
depending on the presence of the rye matrix. For the F supplement the 
maximal enterolactone formation per 10 ml faecal suspension was 200 
nmol and for the R&F supplement it was only 90 nmol (V; Figures 1A 
and B). Thus the suppression caused by the rye matrix also influenced 
enterolactone formation from the flaxseed lignans.  
In the in vivo rat model the presence of rye bran in the diet enhanced 
significantly (P < 0.05) the caecal enterolactone formation from flaxseed 
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in the R&F group (407.1 nmol/g) compared with the groups consuming 
flaxseed (F group: 260.2 nmol/g) or rye bran alone (R group: 72.4 
nmol/g) (V: Table 2). The R group differed significantly from the control 
(C) group (23.8 nmol/g). The caecal enterodiol concentrations were 
significantly higher in the F group (50.0 nmol/g) than in the other test 
groups (0.53.8 nmol/g), suggesting an influence of the rigid flaxseed 
matrix, which is able to retain plant lignans and slow down the conversion 
rate. The rye bran components in the diet enhanced the plant lignan 
conversion from the diets containing flaxseed. The conversion of rye 
lignans to enterolactone has been observed in cannulated pigs (Glitso et 
al. 2000; Bach Knudsen et al. 2003a) and in human subjects (Juntunen et 
al. 2000), which suggests that components of the rye bran matrix do not 
interfere with the enterolactone formation in the in vivo experiments. 
Thus the in vivo enterolactone formation presented here is in agreement 
with the previous in vivo data, but the in vitro data regarding 
enterolactone formation in the presence of rye bran matrix in the present 
thesis is in contradiction to the data regarding the in vivo enterolactone 
formation from rye. This discrepancy required further investigation. 
In a yet unpublished study a phenolic fraction from rye bran was prepared 
and it was fermented in the in vitro colon model using a high dose of the 
substrate (1 g/ fermentation bottle). The phenolic fraction from rye bran 
contained 2 % of phenolic acids and 50 % of carbohydrates, which were 
readily fermented in all experiments. The pH of the faecal samples 
containing the rye phenolic fraction decreased below 5.0 in 2 hours and 
enterolactone formation was not observed at all. Plant lignans remained 
intact during 48 hours of incubation using the dense 16.7 % faecal 
suspension. When the in vitro fermentation experiment was repeated 
using a decreased amount of the rye phenolic fraction (0.25 g), the pH 
values were within physiological limits (above 5.4) and enterolactone was 
formed during the incubations. 
It is possible that the components interfering with enterolactone formation 
could be phenolic acids or SCFA formed from the fermentation of 
carbohydrates. They are both released or fermented during the in vitro 
fermentation, when the rye matrix is present (IV, V). As small molecules, 
phenolic acids may be removed in the dialysis of rye bran extract (IV) or 
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absorbed in vivo. If they are released during the fermentation, their 
removal does not occur in the in vitro colon model and consequently the 
pH in the model decreases and can suppress the enterolactone formation. 
It is also possible that phenolic acids are converted to other microbial 
metabolites, which were not analysed in the present thesis. 
The different influence of rye matrix on enterolactone formation in the in 
vivo rat model and in the in vitro colon model could also be explained by 
differences in the microbiota. There are in general such great differences 
in the metabolical activities of the rat and the human microbiota that 
human microbiota-associated rats are used for metabolical studies 
(Rumney and Rowland, 1992; Bowey et al. 2003). A dense faecal 
suspension (16.7 %; V) is assumed to maintain stability during the 
fermentation (Edwards et al. 1996), whereas the four-week feeding period 
used in the rat model in the present study is such a long time that 
adaptation of the microbiota cannot be avoided (V). This interpretation is 
supported by earlier findings from a feeding experiment, in which a pre-
adaptation period with ferulic acid enhanced the excretion of 
enterolactone in rats after consumption of a diet containing wheat bran 
and ferulic acid (Nicolle et al. 2002). Since rye bran is a good source of 
ferulic acid and its dimers (Andreasen et al. 2000), it is possible that 
ferulic acid in the R and R&F diets further enhanced enterolactone 
formation in the in vivo rat model, increasing the natural difference 
between the microbiota in the human faecal inoculum and in the rat caeca. 
Soluble carbohydrates were also abundantly present in the phenolic fraction 
of rye, causing SCFA formation and decrease of pH (unpublished data). It 
may be postulated that the consumption of nutrients, the release of phenolic 
acids and the accumulation of SCFA results in the low pH, which may have 
affected the activity of the microbiota. These observations suggest that 
enterolactone-converting microbiota is sensitive to low pH. Consequently, 
the conditions may not be physiologically relevant in static batch cultures at 
late time points after 24 hours (Campbell et al. 1992). 
The consumption of glucose during the fermentation occurred at the 
slowest rate in the samples containing the flaxseed (F) supplement (Figure 
11), the pH of which decreased more slowly than that of the samples 
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containing rye bran (R and R&F supplements) (Figure 12). In addition to 
flaxseed meal, the F supplement contained powdered cellulose, which is 
known to have a crystalline structure and a high resistance to fermentation 
by colonic bacteria (McDougall et al. 1996). 
 
 
 
 
 
 
 
 
Figure 11. Consumption of glucose in the in vitro colon model with the 
rye bran (R), flaxseed (F) and rye bran and flaxseed (R&F) supplements 
and in the faecal background. 
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Figure 12. Changes in pH in the in vitro colon model with the rye bran 
(R), flaxseed (F) and rye bran and flaxseed (R&F) supplements and in the 
faecal background. 
Rye bran contained readily fermentable carbohydrates, which was evident 
from the rapid SCFA formation (IV: Figures 3a; V: Figure 1C). The 
presence of rye bran enhanced the butyrate formation both in the in vitro 
fermentation and in the in vivo rat model (IV: Figure 3d; V: Figure 2). A 
high proportion of butyrate has been associated with consumption of rye 
in human subjects (Gråsten et al. 2000) and in animals (Gråsten et al. 
2002; Bach Knudsen et al. 2003b). The SCFA and butyrate productions 
showed a good correlation in our studies in both the in vitro and in vivo 
models. In the case of the SCFA formation, the in vitro fermentation 
model predicted well the responses observed in the in vivo rat model. 
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4.3 Reproducibility of the results from the in vitro 
colon model 
The biological activity of the in vitro colon model originates from pooled 
faecal samples from at least four invidual donors. The biological activity 
of the different inocula is presented below by collating the primary data 
from several experiments. Pre-digested rye bran and pre-digested flaxseed 
meal were used as reference substrates. Means and standard deviations of 
the enterolactone, the enterodiol and the SCFA (as a sum of acetate, 
propionate and butyrate) formations were calculated from triplicate 
measurements (Table 4). The enterolactone formation was at the level of 
that of the faecal background in four individual experiments with pre-
digested rye bran as a substrate (using two 10 % (w/v) and two 16.7 % 
faecal suspensions). High enterolactone formation was observed from 
three experiments with pre-digested flaxseed meal (using one 10 % (w/v) 
and two 16.7 % faecal suspensions). High standard deviations of enterodiol 
and enterolactone formation were observed for flaxseed meal. Flaxseed 
has a rigid cell-wall structure (Freeman 1995), which may have affected 
the release of plant lignans and their metabolism to enterodiol and 
enterolactone.  
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Table 4. Formation of enterodiol, enterolactone and short-chain fatty 
acids (SCFA) (average±standard deviation) from pre-digested rye bran 
and flaxseed meal, and the faecal background in the specific experiments. 
All analyses were performed in triplicate using the 10 % or 16.7 % (w/v) 
faecal suspensions for 24h or 48 h, respectively. 
Sample 
Experiment 
(Faecal 
suspension %, 
w/v) 
 
Enterodiol 
 
(nmol) 
 
Enterolactone 
 
(nmol) 
 
SCFA 
 
(µmol) 
Pre-digested rye 
bran 
Exp 1 (10 %) 
Exp 2 (10 %) 
Exp 3 (16.7 %) 
Exp 4 (16.7 %) 
 
 
6±0 
2±0 
15±1 
14±3 
 
 
14±0 
16±1 
19±1 
21±1 
 
 
820±20 
720±20 
920±80 
870±120 
Pre-digested 
flaxseed meal 
Exp 2 (10 %) 
Exp 3 (16.7 %) 
Exp 5 (16.7 %) 
 
 
46±70 
22±1 
540±250 
 
 
20±20 
840±30 
450±280 
 
 
760±10 
1100±40 
1000±80 
Faecal 
background 
Exp 1 (10 %) 
Exp 2 (10 %) 
Exp 3 (16.7 %) 
Exp 4 (16.7 %) 
Exp 5 (16.7 %) 
 
 
4±0 
0±0 
17±1 
18±0 
0±0 
 
 
14±1 
14±3 
13±0 
44±1 
27±0 
 
 
470±40 
340±50 
680±50 
490±12 
1150±180 
 
When the microbial bioconversion of quercetin was assessed (II), the 
volume of the fermentation vessel or the initial pH of the buffer caused 
some quantitative differences between the series, although the profiles of 
3,4-dihydroxyphenylacetic acid and 3- hydroxyphenylacetic acid were 
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similar (II: Fig. 3a). The profiles of the background metabolites were 
different and they were strongly dependent on the inoculum (II; Fig. 3b). 
All this data shows that the metabolite profiles are qualitatively 
reproducible for each substrate. However, individual variation of the 
microbiota is reflected in the quantitative data. Thus, the results should 
always be shown in reference to the formation of the metabolites in the 
faecal background of the particular experiment. 
The biological activities reflect the composition of the colonic microbiota. 
The quantitation of bacterial species is difficult, because for example 
selective plate-count methods underestimate the abundance of species 
(Apajalahti et al. 2003). Isolation and characterization of the total 
community DNA and additional guanin-cytocin fractionation (%G+C 
profiling) could provide a novel approach to studying differences between 
the inocula (Apajalahti et al. 2004; Holben et al. 2004). These methods 
could be added to the quality management of the in vitro colon model. 
Calculation of means and standard deviations is the only way of 
evaluating the data in triplicate measurements. In order to perform a 
statistical evaluation of the metabolite formation, the number of replicates 
should be increased. Non-parametric tests can be used if the number of 
replicates is higher than six, and the parametric tests require as many as 
twenty replicates. However, the dimensions of the anaerobic chamber 
limit the total number of fermentation bottles in one experiment and one 
inoculum. Thus the number of replicates can be increased only if the 
number of tested substrates is decreased. A fermentation study could be 
designed so that the metabolite profiles first are screened for a large 
number of substrates. The experiment could be repeated with the relevant 
substrates, at crucial time points and with several replicates in another 
experiment, the results of which could be evaluated statistically using for 
example the non-parametric methods. 
Each specific inoculum has a biological activity of its own, which is 
shown as quantitative differences between the experiments. Large 
individual variation has been reported in the biological activities in the 
human colon (Rowland et al. 1999; Lampe 2003). One of the benefits of 
the in vitro colon model is that it avoids the individual variation within 
 77 
each experiment. Despite the quantitative differences between the series, 
it is possible to repeat the response of a substrate with reference to the 
faecal background. An in vivo response can be studied from biological 
fluids in a clinical experiment. After receiving the in vivo metabolite 
profile, microbial metabolites in vitro can be observed against the in vivo 
data, and the role of the microbial bioconversions in the overall 
metabolism of the substrate compound can be observed.  
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5. Conclusions 
Dietary components undergo several tranformations during digestion. 
These reactions affect their bioavailability including the absorption, 
metabolism, transport to the target organs and potential biological effects 
of the active molecules. Clinical trials provide evidence of the health 
effects, but the specific bioconversions occurring at the specific sites 
cannot easily be characterized from the in vivo data. The in vitro digestion 
models facilitate investigation of the roles of specific sites in the 
gastrointestinal tract in digestion and microbial metabolism. The 
microbial metabolism can be studied only by isolating the colonic 
microbiota from the other active sites of metabolism, which justifies the 
development and the use of the in vitro faecal fermentation model. It is 
also very important to introduce the food samples to the in vitro 
fermentation model without such digestible components which would be 
absorbed in the human digestive system. This justifies the use of the 
enzymatic in vitro digestion model. The main target of this thesis was the 
development and use of these two in vitro digestion models. 
The first specific aim was to develop the in vitro enzymatic digestion 
model for the removal of starch from cereal substrates prior to their in 
vitro fermentation. This aim was fulfilled, because the in vitro enzymatic 
digestion model was able to mimic the extent of starch hydrolysis in the 
in vivo data reported in the literature. Furthermore, when dialysis was 
used instead of centrifugation in the separation of the DF residue, soluble 
DF components were retained and the residue resembled better the chyme 
entering the human colon. The enzymatic digestion model is essential as a 
pre-treatment if the sample is introduced to the fermentation model as 
food and not as an isolated DF fraction. In this manner the non-
physiological fermentation of components which would already have 
been absorbed in the small intestine in vivo, could be avoided. 
The second specific aim was the application of the in vitro fermentation 
model using human microbiota to the bioconversion of pure phenolic 
compounds, to the identification of the microbial metabolites and to 
monitoring the time course of the metabolite formation. This aim was 
partly achieved. Two main microbial metabolites were identified and 
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quantitated for quercetin using a substrate-to-inoculum ratio which 
enabled the detection of the metabolites from the faecal background. The 
microbial degradation of anthocyanins occurred only to a much smaller 
extent than that of quercetin. Four microbial metabolites were 
distinguished from the faecal background, but only protocatechuic acid 
was identified with certainty. In addition, there was an unidentified 
compound, a phenoxyacid or a phenoxyaldehyde, present as a ring-fission 
metabolite, and an unidentified aglycone conjugate. This conjugate was 
formed from all the tested anthocyanins, and it was the only microbial 
metabolite when the faecal suspension was dense. The microbial 
population may be more dilute in the distal parts of the ileum in man and 
protocatechuic acid could be formed before the caecum. The anti-
proliferative effect of protocatechuic acid on cancer cell-lines may 
suggest that degradation of anthocyanins by microbiota may be beneficial 
as an anti-cancer agent in the liver and in the colon, the organs which 
participate in phenolic metabolism.  
When the time courses of the microbial metabolites were compared, 
phenolic compounds were converted to their metabolites in the in vitro 
colon model at different rates. The formation of the intermediary 
metabolites could be shown by using diluted inocula. Deconjugation 
occurred within 2 hours using a 1 % faecal suspension, and ring-fission of 
quercetin within 2 hours and subsequent dehydroxylation within 8 hours 
using a 5 % faecal suspension. Enterodiol formation required a dense 
faecal suspension (16.7 %) and a long incubation time (up to 12 h) to 
reach its maximal concentration. Enterolactone conversion was the 
slowest process and the maximum was reached towards the end of the 
incubation time (3648 hours) with the dense (16.7 %) faecal suspension 
in vitro. This may suggest that the microbial population capable of 
enterolactone conversion is not abundant. 
The third aim was to assess the role of the faecal microbiota in the overall 
metabolism of phenolic compounds. This aim could be achieved for 
quercetin, and to a minor extent for anthocyanins. To fully achieve this 
aim all the microbial metabolites should have been identified from the in 
vitro faecal fermentation model and from human biological fluids in vivo. 
Quercetin was degraded to hydroxyphenylacetic acids by microbes, but 
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not methylated. However, there could be other routes of degradation such 
as formation of SCFA or gases, which were not quantitated. Quantitation 
would only have been possible using radiolabelled substrates. In the case 
of anthocyanins identification of one metabolite and proposals for two 
others were achieved. The low extent of the microbial degradation 
suggests that the concentrations of these metabolites in the body fluids 
may be low. It is also possible that most of the anthocyanins are removed 
from the body intact or as conjugates, which may further explain the low 
bioavailability suggested for anthocyanins. In the case of plant lignans, 
the role of microbiota in enterolactone formation has already been 
established in earlier studies and other intermediary metabolites than 
enterodiol were not reported in this study.  
The fourth aim was to assess the role of the rye matrix in the metabolism 
of plant lignans. This aim was partly achieved, because the release and the 
formation of acidic components (phenolic acids and SCFA) from the rye 
matrix decreased the pH of the samples, and consequently suppressed the 
enterolactone formation. When the pH values of the samples were either 
neutral by removal of soluble components after enzymatic hydrolysis (rye 
bran extract), or mildly acidic by decreasing the amount of sample 
(phenolic fraction from rye bran), enterolactone formation was observed. 
The released components or their metabolites are not removed during the 
in vitro fermentation and they may interfere with the microbiota. 
However, we can only speculate which component causes the 
interference. Most probably there are several affecting factors. 
Furthermore, very little is known about the bacterial species which are 
capable of enterolactone formation. If the enterolactone-converting 
species are sensitive to the acidic pH, this observation may help in the 
isolation of this particular microbiota.  
The evidence of the reduced risk of chronic diseases is based on 
epidemiological studies. Case-control studies have been performed in 
order to identify correlations between a disease incidence and a habitual 
conduct and its consequencies (smoking, diet, weight reponse etc.). 
Human interventions or animal trials describe the end-point of the 
metabolism often after a period of adaptation to the components under 
investigation. The in vivo animal models can be used for studies of the 
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mechanisms of action of the biologically active compounds. However, a 
living body is such a complex network of biochemical reactions that 
simplification may facilitate recognition of the crucial reactions occuring 
in the body. The biological activities of the different sites can be studied 
in vitro by isolating for example the epithelial cells, some parts of the 
intestine, the hepatocytes, the colonocytes or microbial populations from 
the host. The in vitro digestion models are a bridge between the analysis 
of food composition and structure on the one hand and human metabolism 
on the other. 
Although the microbial metabolites of flavonoids, phenolic acids and 
phytoestrogens were identified in the 1960s and 1970s, it is surprising that 
this metabolism did not receive much attention between the 1980s and 
2000. Consequently, surprisingly little interest has been focused on the 
biological effects of the microbial metabolites. The recognition of the 
active metabolism in the ileum and the liver has increased the level of 
interest in microbial metabolism. The development of modern analytical 
equipment has enabled quantitation of the metabolites, which is important 
in order to elucidate their relevance to human health. Studies of biological 
activity and bioavailability have been performed for components detected 
from food. It has been suggested that compounds should be introduced to 
the in vitro assays of biological activity in forms and at concentrations 
which are relevant in vivo. In addition, the lack of knowledge concerning 
the biological activities of the microbial metabolites demands attention 
from the scientific community. 
In the future the in vitro digestion models could also be applied to 
pharmaceutical research. Traditional dissolution tests, comparable to the 
enzymatic in vitro digestion model, are designed for medicinal 
formulations. Furthermore, the enzymatic in vitro digestion model could 
be used for studying the interactions between food components and 
medicines. The in vitro colon model has not been used extensively for 
pharmaceutical research. However, the microbial metabolism of 
controlled release medicinal compounds could be studied in the in vitro 
colon model. The whole metabolome could be analysed by observing a 
broad range of putative metabolites from the in vitro fermentation model 
with the aid of bioinformatics. Furthermore, the adverse effects of the 
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candidate molecules could be predicted by identifying the toxic 
metabolites. The in vitro colon model could be validated by comparing 
the in vitro results of known medicines with the data from human clinical 
trials. 
The real benefit of the colon model is demonstrated if the model 
facilitates identification of the metabolites circulating in the human body. 
Time and resources can be saved in the screening of new candidate 
molecules if precursors for the toxic metabolites can be ruled out or if the 
precursors of the therapeutic metabolites can be included before a clinical 
trial. Thus the in vitro colon model could be used as a pilot trial in the 
pre-clinical stage of drug development. 
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